Document:

Form of Note and Warrant Purchase Agreement effective April 20, 2004

 Exhibit 10.15 
  
 NOTE AND WARRANT PURCHASE AGREEMENT 
  
 THIS NOTE AND WARRANT PURCHASE AGREEMENT (this “Agreement”) is made effective as of April 20, 2004,
by and among Lumera Corporation, a Washington corporation (the “Company”), and the persons or entities listed on Schedule 1 hereto (each a “Lender” and, collectively, the
“Lenders”). 
  
 RECITALS:

  
 A. The Lenders are willing to lend to the Company on the
terms and conditions set forth in this Agreement, the form of Convertible Promissory Note attached hereto as Exhibit A (each a “Note” and all Notes issued to Lenders, collectively, the
“Notes”), and the form of warrant attached hereto as Exhibit B (each a “Warrant” and all Warrants issued to Lenders, collectively, the “Warrants”). 
  
 B. At the completion of the sale of Notes and Warrants to Lenders under this
Agreement, the aggregate amount of principal outstanding under the Notes will be not greater than $2,300,000. 
  
 AGREEMENT: 
  
 In consideration of the mutual promises and covenants set forth herein, the parties hereby agree as follows: 
  

	1.	Issuance of Securities 

  

	 	1.1	Issuance and Sale of Notes 

  
 Subject to the terms and conditions of this Agreement, each Lender agrees to purchase, and the Company agrees to issue and sell to such Lender, the
following: 
  
 (a) a Note in the principal amount
set forth opposite such Lender’s name on Schedule 1 hereto, which Note is convertible at the Lender’s election into shares of Common Stock. For purposes of this Agreement and the Notes and Warrants issued hereunder, “Common
Stock” means the Company’s Class A common stock, no par value per share (the “Class A Common Stock”), or, if the Class A Common Stock has been converted into another class of common stock, the class of
common stock as then authorized; and 
  
 (b) a
Warrant to purchase shares of Common Stock, such Warrant to be in the Form of Exhibit B and which shall be exercisable for a number of shares of Common Stock as set forth in Exhibit B. 
  

	 	1.2	Closing 

  
 (a) The initial closing (the “Initial Closing”) of the purchase of the Notes and Warrants in return for the
consideration provided shall be held at the offices of Perkins Coie LLP, 1201 Third Avenue, Suite 4800, Seattle, Washington, at 10:00 a.m., April 20, 2004, or at such other time and place as the Company and the Lenders acquiring Notes representing a
majority of the aggregate principal amount of the Notes may agree orally or in writing. 
  
 (b) At any time until Notes with an aggregate original principal amount of $2,300,000 have been issued, subsequent closings (each a
“Subsequent Closing”) of the financing may be held at such time and place as shall be mutually agreed upon by the Company and the lenders who are participating in such Subsequent Closing. At any Subsequent Closing, the name
of each additional Lender shall be added to Schedule 1 hereto and each additional Lender that is issued a Note and Warrant at such Subsequent Closing shall become a party hereto by execution of a counterpart of the signature page, in each case
without the necessity of formal amendment hereto. For purposes of this Agreement, unless the context otherwise requires, the term “Closing” shall refer, with respect to each Lender, to the date of the specific closing at
which such Lender is issued a Note and Warrant by the Company. At each Closing, each Lender purchasing a Note and Warrant at such Closing shall deliver the principal amount set forth opposite such Lender’s name on Schedule 1 hereto via wire
transfer of immediately available funds or check to the Company, and the Company shall deliver to such Lender an executed Note and Warrant in return for the consideration provided to the Company. The purchase price of each Note shall be equal to
100% of the original principal amount thereof, and the purchase price of each Warrant shall be equal to $0.001 per share of Common Stock for which such Warrant may be exercised. 
  

	2.	Representations and Warranties of the Company 

  
 In connection with the transactions provided for herein, the Company hereby represents and warrants to the Lenders that: 
  

	 	2.1	Due Incorporation; Valid Existence 

  
 The Company is a corporation duly incorporated and validly existing under the laws of the State of Washington and has all requisite
corporate power and authority to carry on its business as now conducted. The Company is duly qualified to transact business and is in good standing in each jurisdiction in which the failure so to qualify would have a material adverse effect on its
business or properties. 
  

 -2- 

	 	2.2	Authorization 

  
 All corporate action on the part of the Company, its officers, directors, and shareholders necessary for the authorization, execution, and delivery of
this Agreement and the performance of all obligations of the Company hereunder, and the authorization, issuance (or reservation for issuance), and delivery of the Notes and Warrants (collectively, the “Securities”), has been
taken or will be taken prior to the Closing. This Agreement and the Securities, when executed and delivered by the Company, shall constitute valid and legally binding obligations of the Company, enforceable in accordance with their terms, except (a)
as limited by applicable bankruptcy, insolvency, reorganization, moratorium, and other laws of general application affecting enforcement of creditors’ rights generally and (b) as limited by laws relating to the availability of specific
performance, injunctive relief, or other equitable remedies. 
  

	 	2.3	No Approvals; No Conflicts 

  
 The execution, delivery and performance of this Agreement by the Company and the consummation of the transactions contemplated hereby will not (with or
without the giving of notice or lapse of time, or both) (a) constitute a violation of any provision of law or any judgment, decree, order, regulation or rule of any court or other governmental authority applicable to the Company, (b) require any
consent, approval or authorization of, or declaration, filing or registration with, any person, regulatory body or governmental agency, except for the filing of notices of the sale of the Notes pursuant to Regulation D promulgated under the Act and
applicable state securities laws, which filings will be effected within fifteen days of the Initial Closing, and, if necessary, any Subsequent Closing, (c) require any consent or approval under, or result in any default under, acceleration or
termination of, or the creation in any party of the right to accelerate, terminate, modify or cancel, any agreement, lease, note or other restriction, encumbrance, obligation or liability to which the Company is a party or by which it is bound or to
which any assets of the Company are subject, (d) conflict with or result in a breach of or constitute a default under any provision of the Articles of Incorporation or Bylaws of the Company or (e) result in the suspension, revocation, impairment,
forfeiture or nonrenewal of any permit, license, authorization or approval applicable to the Company, its business or operations or any of its assets or properties. 
  

	 	2.4	Valid Issuance of Stock 

  
 The Common Stock, if and when issued in accordance with the terms of the Notes and the Warrants for the consideration expressed therein, will be duly and
validly issued, fully paid, and nonassessable and, based in part upon the representations of the Lenders in this Agreement, will be issued in compliance with all applicable federal and state securities laws. 
  

 -3- 

	 	2.5	Restricted Securities 

  
 The Company acknowledges that the Securities have not been registered with the Securities and Exchange Commission (“SEC”) under
the Securities Act of 1933, as amended (the “Act”), and covenants that the Securities will be offered and sold in compliance with an exemption from registration provided by Rule 506 of Regulation D of the Act. Notwithstanding
the foregoing, the parties hereto acknowledge the registration provisions relating to certain of the Securities as set forth in Section 5 of this Agreement. 
  

	 	2.6	Capitalization 

  
 The authorized capital of the Company consists, or will consist, immediately prior to the Initial Closing, of: 
  
 (a) 5,550,000 shares of Preferred Stock, of which (i)
2,550,000 shares have been designated Series A Preferred, 2,400,000 of which are issued and outstanding immediately prior to the Initial Closing, and 150,000 of which have been reserved and are subject to issuance upon the exercise of currently
outstanding warrants, and (ii) 3,000,000 shares have been designated Series B Preferred, 1,585,025 of which are issued and outstanding immediately prior to the Initial Closing. All of the outstanding shares of Series A Preferred and Series B
Preferred have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. 
  
 (b) 3,000,000 shares of the Company’s common stock, no par value per share of which (i) 20,000,000 shares have been designated Class
A Common Stock, 802,414 shares of which are issued and outstanding immediately prior to the Initial Closing, and (ii) 10,000,000 shares of which have been designated Class B Common Stock, 5,370,000 shares of which are issued and outstanding
immediately prior to the Initial Closing. All of the outstanding shares of Class A Common Stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws. The
Company has reserved the number of shares of Class A Common Stock required for issuance upon conversion of the Series A Preferred, Series B Preferred and Class B Common Stock. 
  
 (c) The Company has reserved 3,000,000 shares of Class A Common Stock for issuance to officers, directors,
employees and consultants of the Company pursuant to its 2000 Stock Option Plan, duly adopted by the Board of Directors and approved by the Company’s shareholders (the “Stock Incentive Plan”). Of such reserved shares of
Class A Common Stock, as of the Initial Closing, options to purchase 1,542,330 shares have been granted and are currently outstanding, and 1,457,670 shares of Class A Common Stock remain available for issuance to officers, directors, employees and
consultants pursuant to the Stock Incentive Plan. 
  

 -4- 

 (d) Except for (i) this Agreement, (ii) the conversion privileges of the Series A
Preferred and Series B Preferred, (iii) the rights of purchase and co-sale set forth in Section 3 of the Amended and Restated Right of First Refusal and Co-Sale Agreement dated as of August 25, 2003 among the Company and the parties listed therein,
(iv) the right of participation set forth in Section 2.3 of the Amended and Restated Investors’ Rights Agreement dated as of August 25, 2003 among the Company and the parties listed therein, (v) currently outstanding options to purchase
1,541,330 shares of Class A Common Stock granted pursuant to the Stock Incentive Plan, and (vi) currently outstanding warrants exercisable for 164,000 shares of Class A Common Stock, there are no outstanding options, warrants, rights (including
conversion or preemptive rights and rights of first refusal or similar rights) or agreements, orally or in writing, for the purchase or acquisition from the Company of any shares of its capital stock. 
  

	 	2.7	Litigation 

  
 There is no action, suit, proceeding or investigation pending or currently threatened against the Company or any of its subsidiaries that questions the
validity of the Agreement, the Notes and Warrants or the right of the Company to consummate the transactions contemplated hereby or thereby, or that might result, either individually or in the aggregate, in any material adverse change in the assets,
condition or affairs of the Company, financially or otherwise, or any change in the current equity ownership of the Company, nor is the Company aware that there is any basis for the foregoing. Neither the Company nor any of its subsidiaries is a
party or subject to the provisions of any order, writ, injunction, judgment or decree of any court or government agency or instrumentality. There is no action, suit, proceeding or investigation by the Company or any of its subsidiaries currently
pending or which the Company or any of its subsidiaries intends to initiate. 
  

	3.	Representations and Warranties of the Lenders 

  
 In connection with the transactions provided for herein, each of the Lenders, severally and not jointly, hereby represents, warrants and covenants (which
representations, warranties and covenants will survive the Closing) to the Company that: 
  
 3.1 such Lender understands and agrees that the Securities have not been registered under the Act and the Securities are being offered and sold by the Company to such Lender in reliance upon an exemption from
registration provided by Rule 506 of Regulation D under the Act; 
  
 3.2 such Lender is authorized to consummate the purchase of the Securities and the securities that may be acquired on conversion of the Securities (the Securities and 

  

 -5- 

 
such other securities that may be acquired on conversion, collectively, the “Transaction Securities”); 
  
 3.3 such Lender has such knowledge, sophistication and experience in
financial and business matters as to be capable of evaluating the merits and risks of the investment in the Transaction Securities, and is able to bear the economic risk of loss of the investment; 
  
 3.4 such Lender is an “accredited investor” within the
meaning of Rule 501(a) of Regulation D under the Act (“Accredited Investor”) and is purchasing the Transaction Securities for his, her or its own account for investment and not with a view to any resale, distribution or other
disposition of the Transaction Securities or any part thereof in any transaction that would be in violation of the securities laws of the United States or any State thereof; 
  
 3.5 such Lender is not purchasing any of the Transaction Securities as a result of any form of general solicitation
or general advertising, as those terms are used in Regulation D under the Act, including advertisements, articles, notices or other communications published in any newspaper, magazine or similar media or broadcast over radio, or television, or any
seminar or meeting whose attendees have been invited by general solicitation or general advertising; 
  
 3.6 if such Lender decides to offer, sell or otherwise transfer any of the Transaction Securities, such Lender will not offer, sell or otherwise
transfer any of such securities directly or indirectly, unless: 
  
 (a) the sale is to the Company; 
  
 (b) the sale is made pursuant to an effective registration statement; 
  
 (c) the sale is made in compliance with the exemption from the registration requirements under the Act provided by Rule 144, Rule 145 or
Rule 144A thereunder, if available, and in accordance with any applicable state securities or “Blue Sky” laws; or 
  
 (d) the securities are sold in a transaction that does not require registration under the Act or any applicable U.S. state laws and
regulations governing the offer and sale of securities, and such Lender has prior to such sale furnished to the Company an opinion of counsel to that effect which is satisfactory to the Company, or the Company has otherwise satisfied itself that
such registration is not required, provided that none of the restrictions hereunder shall restrict any pledge of the Transaction Securities to 

  

 -6- 

 
a bank or other financial institution that creates a mere security interest in such Transaction Securities in connection with a bona fide loan transaction;

  
 3.7 such Lender understands and acknowledges that the
Transaction Securities are “restricted securities” and upon the original issuance thereof, and until such time as the same is no longer required under the applicable requirements of the Act or applicable U.S. state laws and regulations,
the certificates representing the Transaction Securities will bear a legend in substantially the following form: 
  
 NEITHER THE SECURITIES REPRESENTED NOR THE SECURITIES ISSUABLE UPON EXERCISE OR CONVERSION THEREOF HEREBY HAVE BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE COMPANY THAT SUCH SECURITIES MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED ONLY (A) TO THE COMPANY,
(B) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT, (C) IN ACCORDANCE WITH RULE 144, RULE 145 OR RULE 144A UNDER THE SECURITIES ACT, IF APPLICABLE, AND IN ACCORDANCE WITH ANY APPLICABLE STATE SECURITIES OR “BLUE SKY” LAWS OR (D) IF THE
COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY, OR OTHERWISE SATISFIED ITSELF, THAT THE TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE U.S. STATE LAWS AND REGULATIONS GOVERNING
THE OFFER AND SALE OF SECURITIES. 
  
 3.8 such Lender has
been afforded the opportunity (i) to ask such questions as such Lender has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Transaction Securities and (ii) to
obtain such additional information which the Company possesses or can acquire without unreasonable effort or expense necessary to verify the accuracy and completeness of the information requested and that such Lender has considered necessary in
connection with its decision to invest in the Transaction Securities; 
  
 3.9 such Lender understands that the Company shall instruct its transfer agent to refuse to register any transfer of Transaction Securities without first being notified by the Company that it is satisfied that such transfer is exempt
from or not subject to the registration requirements of the Act; 
  

 -7- 

 3.10 such Lender consents to the Company making a notation on its records or giving instruction to
the registrar and transfer agent of the Company in order to implement the restrictions on transfer set forth and described herein; 
  
 3.11 the address of such Lender at which such Lender received and accepted the offer to purchase the Securities is the address listed on Schedule 1
to this Agreement; 
  
 3.12 such Lender agrees that by
accepting Securities, he, she or it shall be representing and warranting that the representations and warranties in this Section 3 are true as at the Closing with the same force and effect as if they had been made by it at the Closing and will be
true and correct as of the conversion of the Securities with the same force and effect as if they had been made by it as of the date of such conversion, and that they shall survive the purchase of Securities and the Transaction Securities and shall
continue in full force and effect notwithstanding any subsequent disposition by it of any of the Transaction Securities; and 
  
 3.13 such Lender understands that the Company is an early-stage company with a limited operating history and is subject to the high level of risk,
and that an investment in the Transaction Securities is speculative, involves a high degree of risk and may result in a loss of all of such Lender’s investment in the Transaction Securities. 
  

	4.	Information Rights 

  
 Upon the request of a Lender, the Company will deliver to such Lender (a) audited financial statements of the Company no later than 90 days after the end
of each fiscal year, (b) unaudited quarterly financial statements no later than 45 days after the end of each of the first three quarters, and (c) unaudited monthly financial statements no later than 30 days after the end of each month. 

 

	5.	Registration Rights 

  

	 	5.1	Definitions 

  
 For purposes of this Section 5: 
  
 (a) The terms “register,” “registered,” and “registration” refer
to a registration effected by preparing and filing a registration statement or similar document in compliance with the Act, and the declaration or ordering of effectiveness of such registration statement or document; 
  
 (b) The term “Registrable
Securities” means (i) the shares of Common Stock issuable or issued upon exercise of the Warrants, and, if the underwriter for the IPO (defined below) releases the Holder from the restrictions of any lockup agreement relating to the
transfer of shares of Common Stock issuable or issued upon conversion of the 

  

 -8- 

 
Notes or otherwise approves such proposed transfer, the shares of Common Stock issuable or issued upon conversion of the Notes and (ii) any other shares of
Common Stock issued (or issuable upon the conversion of any warrant, right or other security which is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares listed in (i); provided, however,
that the foregoing definition shall exclude in all cases any Registrable Securities sold by a person in a transaction in which his or her rights under this Agreement are not assigned. Notwithstanding the foregoing, Common Stock or other securities
shall only be treated as Registrable Securities if and so long as they have not been (A) sold to or through a broker or dealer or underwriter in a public distribution or a public securities transaction, or (B) sold in a transaction exempt from the
registration and prospectus delivery requirements of the Act under Section 4(1) thereof or Rule 144 thereunder so that all transfer restrictions, and restrictive legends with respect thereto, if any, are removed upon the consummation of such sale;

  
 (c) The number of shares of
“Registrable Securities then outstanding” shall be determined by the number of shares of Common Stock outstanding which are, and the number of shares of Common Stock issuable pursuant to then exercisable or convertible
securities which are, Registrable Securities under this Agreement; 
  
 (d) The term “Holder” means any person owning or having the right to acquire Registrable Securities; and 
  
 (e) The term “SEC” means the Securities and Exchange Commission. 
  

	 	5.2	Registration 

  
 (a) The Company shall use its reasonable best efforts to file, within six months after the effective date of the first registration
statement for a public offering of securities of the Company (other than a registration statement relating either to the sale of securities to employees of the Company pursuant to a stock option, stock purchase or similar plan approved by the Board
of Directors of the Company or an SEC Rule 145 transaction approved by the Board of Directors of the Company) (the “IPO”), a registration statement under the Act (the “Registration Statement”) covering
the registration of the Registrable Securities then outstanding. The Company shall notify each Holder of the proposed filing at least 20 days prior to the filing of the Registration Statement (such notice, the “Notice to
Holders”). The Holders acknowledge and agree that all of the Registrable Securities of such Holders (other than any Holder that notifies the Company within 10 days of the giving of the Notice to Holders that such Holder does not want
part or all of the Holder’s Registrable Securities included in the Registration Statement and specifies the number of shares to be excluded from the Registration Statement (such notice, an “Opt Out Notice”)), shall be
included in the Registration 

  

 -9- 

 
Statement. The Holders whose Registrable Securities are included in the Registration Statement are referred to in this Agreement as “Registering
Holders.” Notwithstanding the foregoing and the other provisions of this Section 5, the Company shall not have any obligation to file any Registration Statement hereunder if the Company has received Opt Out Notices covering more than
35% of the Registrable Securities. Subject to the limitations of this Section 5.2, the Company may also include shares of its capital stock in such registration. 
  
 (b) If Registering Holders holding a majority in interest of the Registrable Securities covered by the
Registration Statement intend to distribute such Registrable Securities by means of an underwriting, they shall so advise the Company in writing. The underwriter will be selected by Registering Holders of a majority in interest of the Registrable
Securities covered by the Registration Statement and shall be reasonably acceptable to the Company. In such event, the right of any Registering Holder to include the Registering Holder’s Registrable Securities in such registration shall be
conditioned upon such Registering Holder’s participation in such underwriting and the inclusion of such Registering Holder’s Registrable Securities in the underwriting (unless otherwise mutually agreed by Registering Holders holding a
majority in interest of Registrable Securities covered by the Registration Statement) to the extent provided herein. In such event, all Registering Holders shall (together with the Company as provided in subsection 5.3(e)) enter into an underwriting
agreement in customary form with the underwriter or underwriters selected for such underwriting. Notwithstanding any other provision of this Section 5.2, if the underwriter advises the Registering Holders in writing that marketing factors require a
limitation of the number of shares to be underwritten then the number of shares of Registrable Securities that may be included in the underwriting shall be allocated among all Registering Holders, in proportion (as nearly as practicable) to the
amount of Registrable Securities of the Company owned by each Registering Holder; provided, however, that the number of shares of Registrable Securities to be included in such underwriting shall not be reduced unless all other
securities are first entirely excluded from the underwriting; provided, further, that notwithstanding the foregoing, if the University of Washington (the “University”) requests, pursuant to the Restricted Stock
Purchase Agreement dated October 20, 2000 between the University and the Company, to include in a registration pursuant to this Section 5.2 shares of the Company’s Common Stock held by the University (the “UW Shares”),
the number of securities to be registered in such registration shall be allocated among the Registering Holders and the University in proportion (as nearly as practicable) to the amount of the Company’s securities held by each Registering
Holder and the University, provided that the number of UW Shares shall not be reduced below twenty percent (20%) of the number of securities to be registered in such registration. 
  

 -10- 

	 	5.3	Obligations of the Company 

  
 Whenever required under this Section 5 to use its reasonable best efforts to effect the registration of any Registrable Securities, the Company shall, as
expeditiously as reasonably possible, use its reasonable best efforts to: 
  
 (a) Prepare and file with the SEC a registration statement with respect to such Registrable Securities and use reasonable best efforts to cause such registration statement to become effective, and, upon the request of
the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for up to one hundred eighty (180) days. The Company shall not be required to file, cause to become effective or maintain the
effectiveness of any registration statement that contemplates a distribution of securities on a delayed or continuous basis pursuant to Rule 415 under the Act; provided, however, that the Company will only be required to keep such
registration statement effective for up to one hundred eighty (180) days. 
  
 (b) Prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions
of the Act with respect to the disposition of all securities covered by such registration statement for up to one hundred eighty (180) days. 
  
 (c) Furnish to the Holders such numbers of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements
of the Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them. 
  
 (d) Use reasonable best efforts to register and qualify the securities covered by such registration statement under such other securities
or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to
service of process in any such states or jurisdictions, and in which the Company is not already qualified to do business or subject to service of process. 
  
 (e) In the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the managing underwriter of such offering. Each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement. 
  
 (f) Notify each Registering Holder at any time when a prospectus relating to Registrable Securities covered
by such Registration Statement is required to be delivered under the Act of the happening of any event as a result of which the prospectus 

  

 -11- 

 
included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be
stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing, such obligation to continue for one hundred eighty (180) days. 
  
 (g) Cause all such Registrable Securities registered hereunder to be listed on each securities exchange or
over-the-counter market on which similar securities issued by the Company are then listed. 
  
 (h) Provide a transfer agent and registrar for all Registrable Securities registered pursuant hereunder and a CUSIP number for all such
Registrable Securities, in each case not later than the effective date of such registration. 
  
 (i) Use reasonable best efforts to furnish, at the request of any Registering Holder, on the date that such Registrable Securities are
delivered to the underwriters for sale in connection with a registration pursuant to this Section 5:(i) an opinion, dated such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is
customarily given to underwriters in an underwritten public offering, addressed to the underwriters, and to the Registering Holders and (ii) a letter dated such date, from the independent certified public accountants of the Company, in form and
substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters and to the Registering Holders. 
  

	 	5.4	Furnish Information 

  
 It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section 5 with respect to the Registrable
Securities of any Registering Holder that such Registering Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities as shall be required
to effect the registration of such Registering Holder’s Registrable Securities. 
  

	 	5.5	Expenses of Registration 

  
 All expenses other than underwriting discounts and commissions incurred in connection with registrations, filings or qualifications pursuant to Section
5.2, including (without limitation) all registration, filing and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company, and the reasonable and documented fees and disbursements of one counsel for
the selling Holders selected by them not to exceed $20,000 shall be borne by the Company. 
  

 -12- 

	 	5.6	Delay of Registration 

  
 No Holder shall have any right to obtain or seek an injunction restraining or otherwise delaying any such registration as the result of any controversy
that might arise with respect to the interpretation or implementation of this Section 5. 
  

	 	5.7	Indemnification 

  
 In the event any Registrable Securities are included in a registration statement under this Section 5: 
  
 (a) To the extent permitted by law, the Company will
indemnify and hold harmless each Registering Holder, any underwriter (as defined in the Act) for such Registering Holder and each person, if any, who controls such Registering Holder or underwriter within the meaning of the Act or the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Act, the Exchange Act or other federal or state law,
insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (each, a “Violation”): (i) any untrue statement
or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission to
state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Act, the Exchange Act, any state securities law or any rule or
regulation promulgated under the Act, the Exchange Act or any state securities law; and the Company will pay to each such Registering Holder, underwriter or controlling person, as incurred, any legal or other expenses reasonably incurred by them in
connection with investigating or defending any such loss, claim, damage, liability, or action; provided, however, that the indemnity agreement contained in this subsection 5.7(a) shall not apply to amounts paid in settlement of any
such loss, claim, damage, liability, or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable to any Registering Holder, underwriter or
controlling person for any such loss, claim, damage, liability, or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in
connection with such registration by any such Registering Holder, underwriter or controlling person. 
  
 (b) To the extent permitted by law, each Registering Holder will indemnify and hold harmless the Company, each of its directors, each of
its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Act, any underwriter, any other Registering Holder and any 

  

 -13- 

 
controlling person of any such underwriter or other Registering Holder, against any losses, claims, damages, or liabilities (joint or several) to which any
of the foregoing persons may become subject, under the Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereto) arise out of or are based upon any Violation, in each
case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Registering Holder expressly for use in connection with such registration; and each such Registering
Holder will pay, as incurred, any legal or other expenses reasonably incurred by any person indemnified pursuant to this subsection 5.7(b), in connection with investigating or defending any such loss, claim, damage, liability, or action;
provided, however, that the indemnity agreement contained in this subsection 5.7(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without the consent
of the Registering Holder, which consent shall not be unreasonably withheld; provided, that in no event shall any indemnity under this subsection 5.7(b) exceed the net proceeds from the offering received by such Registering Holder except in the case
of fraud by such Registering Holder. 
  
 (c)
Promptly after receipt by an indemnified party under this Section 5.7 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying
party under this Section 5.7, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any
other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties which may be
represented without conflict by one counsel) shall have the right to retain one separate counsel, with the reasonable and documented fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel
retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written notice to the
indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its ability to defend such action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 5.7, but the
omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 5.7. 
  
 (d) If the indemnification provided for in this Section 5.7 is held by a court of competent jurisdiction to
be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to therein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the 

  

 -14- 

 
amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to
reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection with the Violation that resulted in such loss, liability, claim, damage or expense as well as any other relevant equitable
considerations; provided, that in no event shall any contribution by a Registering Holder under this subsection 5.7(d) exceed the net proceeds from the offering received by such Registering Holder except in the case of fraud by such
Registering Holder. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the Violation relates to information supplied by the indemnifying party or by the
indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such Violation. 
  
 (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 
  
 (f) The obligations of the Company and Registering Holders under this Section 5.7 shall survive the
completion of any offering of Registrable Securities in a registration statement and the termination of this Agreement. 
  

	 	5.8	Reports under the Exchange Act 

  
 With a view to making available to the Holders the benefits of Rule 144 promulgated under the Act and any other rule or regulation of the SEC that may at
any time permit a Holder to sell securities of the Company to the public without registration, the Company agrees to: 
  
 (a) make and keep public information available, as those terms are understood and defined in SEC Rule 144, at all times after ninety (90)
days after the effective date of the first registration statement filed by the Company for the offering of its securities to the general public so long as the Company remains subject to the periodic reporting requirements under Sections 13 or 15(d)
of the Exchange Act; 
  
 (b) file with the SEC in
a timely manner all reports and other documents required of the Company under the Act and the Exchange Act; and 
  
 (c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) a written statement by the
Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of the first registration statement filed by the Company), the 

  

 -15- 

 
Act and the Exchange Act (at any time after it has become subject to such reporting requirements), (ii) a copy of the most recent annual or quarterly report
of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC which permits the selling of any such securities
without registration or pursuant to such form. 
  

	 	5.9	Market Standoff Agreement 

  
 Each Holder hereby agrees that, except pursuant to a registration pursuant to the provisions of Section 5.2, during the period of duration (up to, but not
exceeding, six months) specified by the Company and an underwriter of Common Stock or other securities of the Company, following the effective date of a registration statement of the Company filed under the Act, it shall not, to the extent requested
by the Company and such underwriter, directly or indirectly sell, offer to sell, contract to sell (including, without limitation, any short sale), grant any option to purchase or otherwise transfer or dispose of (other than to donees who agree to be
similarly bound) any securities of the Company held by it at any time during such period except Common Stock included in such registration; provided, however, that: 
  
 (a) such agreement shall be applicable only to the first such registration statement of the Company which
covers Common Stock (or other securities) to be sold on its behalf to the public in an underwritten offering; and 
  
 (b) all officers and directors of the Company and all two-percent (2%) securityholders, and all other persons with registration rights
(whether or not pursuant to this Agreement) enter into similar agreements, except that the University of Washington shall only be required to do so to the extent required under the terms of the Restricted Stock Purchase Agreement between the Company
and the University of Washington dated October 20, 2000. 
  
 In order to enforce
the foregoing covenant, the Company may impose stop transfer instructions with respect to the Registrable Securities of each Holder (and the shares or securities of every other person subject to the foregoing restriction) until the end of such
period, and each Holder agrees that, if so requested, such Holder will execute an agreement in the form provided by the underwriter containing terms which are essentially consistent with the provisions of this Section 5.9. 
  
 Notwithstanding the foregoing, the obligations described in this Section 5.9 shall not apply
to a registration relating solely to employee benefit plans on Form S-8 or similar forms which may be promulgated in the future, or a registration relating solely to an SEC 

  

 -16- 

 
Rule l45 transaction on Form S-4 or similar forms which may be promulgated in the future. 
  

	6.	Miscellaneous 

  

	 	6.1	Successors and Assigns 

  
 Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective
successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities
under or by reason of this Agreement, except as expressly provided in this Agreement. Notwithstanding the foregoing, this Agreement and the Note and Warrant issued hereunder shall not be assignable without the prior written consent of the Company.

  

	 	6.2	Governing Law; Jurisdiction 

  
 This Agreement shall be governed by and construed under the laws of the State of Washington as applied to agreements among Washington residents, entered
into and to be performed entirely within the State of Washington, without giving effect to principles of conflicts of law. The parties irrevocably consent to the jurisdiction and venue of the state and federal courts located in King County,
Washington in connection with any action relating to this Agreement. 
  

	 	6.3	Counterparts 

  
 This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and
the same instrument. 
  

	 	6.4	Titles and Subtitles 

  
 The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in construing or interpreting this Agreement.

  

	 	6.5	Notices 

  
 Unless otherwise provided, any notice required or permitted under this Agreement shall be given in writing and shall be deemed effectively given (a) upon
personal delivery to the party to be notified, (b) upon confirmation of receipt by fax by the party to be notified, (c) one business day after deposit with a reputable overnight courier, prepaid for overnight delivery and addressed as set forth in
(d) or (d) three days after deposit with the United States Post Office, postage prepaid, registered or certified with return receipt 

  

 -17- 

 
requested and addressed to the party to be notified at the address indicated below, or at such other address as such party may designate by 10 days’
advance written notice to the other parties hereto given in the foregoing manner. 
  
 If to the Company: 
  
 Lumera
Corporation 
 P.O. Box 3040 
 Bothell, WA 98041-3040 
 Attn: Chief Executive Officer 
 Fax: (425) 398-6501 
  
 With a
copy to: 
  
 David F. McShea 
 Lance W. Bass 
 Perkins Coie LLP 

1201 Third Avenue, Suite 4800 
 Seattle,
Washington 98101: 
 Fax: (206) 359-9000 
  
 If to the Lender: 
  
 At the address or fax number for such Lender shown on Schedule 1 hereto. 
  

	 	6.6	Expenses; Attorneys’ Fees 

  
 Each party shall bear its own expenses in connection with this Agreement and the transactions contemplated hereby. If any action at law or in equity is
necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which such party may be entitled.

  

	 	6.7	Finder’s Fee 

  
 Each Lender agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the nature of a finder’s
fee (and the costs and expenses of defending against such liability or asserted liability) for which each Lender or any of its officers, employees, or representatives is responsible. The Company agrees to indemnify and hold harmless each Lender from
any liability for any commission or compensation in the nature of a finder’s fee (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers, employees or representatives
is responsible. 
  

 -18- 

	 	6.8	Entire Agreement 

  
 This Agreement and the other documents delivered pursuant hereto constitute the full and entire understanding and agreement between the parties with
regard to the subjects hereof and thereof and supersedes any prior written or oral agreements or understandings. In the event that any signature is delivered by facsimile transmission, such signature shall create a valid and binding obligation of
the executing party with the same force and effect as if such facsimile signature page were an original thereof. 
  

	 	6.9	Amendments and Waivers 

  
 Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and
either retroactively or prospectively), with the written consent of the Company and holders of a majority of the principal amount of the outstanding Notes affected by such amendment or waiver, including the Lead Investor as set forth on Schedule 1.
The parties hereby agree that the addition of any Lender to Schedule 1 to this Agreement and the execution by any such additional Lender of a signature page to this Agreement shall not be considered an amendment hereto under this Section 4.9.

  

	 	6.10	Severability 

  
 If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded from this Agreement and
the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in accordance with its terms. 
  
 [Signature page follows.] 
  

 -19- 

 IN WITNESS WHEREOF, the Company has executed this Agreement as of the date first above written.

  

					
	 	 	LUMERA CORPORATION
			
	 	 	By:	 	 
	 	 	 	 	

	 	 	 Name:
	 	 Thomas D. Mino

	 	 	 Its:
	 	 Chief Executive Officer

		
	 Address:
	 	P.O. Box 3040
Bothell, WA 98041-3040

  
  

 IN WITNESS WHEREOF, the Lenders have executed this Agreement effective as of the date first above
written. 
  

					
	 	 	INDIVIDUAL Lender:
			
	 	 	Signature:	 	  

	 	 	 Name:
	 	  

		
	 Address:
	 	  

	 	 	  

	 Fax:
	 	  

  

							
		
	 	 	ENTITY Lender:
			
	 	 	Name of Entity:	 	  

	 	 	 	 	 By:
	 	  

	 	 	 	 	 Its:
	 	  

		
	 Address:
	 	  

	 	 	  

	 Fax:
	 	  

  
  

 EXHIBIT A 
 to 
 NOTE PURCHASE AGREEMENT 
  
 FORM OF CONVERTIBLE PROMISSORY NOTE 
  
 NEITHER THE SECURITIES REPRESENTED HEREBY NOR THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE BEEN REGISTERED UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE COMPANY THAT SUCH SECURITIES MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED ONLY (A) TO THE COMPANY,
(B) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT, (C) IN ACCORDANCE WITH RULE 144, RULE 145 OR RULE 144A UNDER THE SECURITIES ACT, IF APPLICABLE, AND IN ACCORDANCE WITH ANY APPLICABLE STATE SECURITIES OR “BLUE SKY” LAWS OR (D) IF THE
COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY, OR OTHERWISE SATISFIED ITSELF, THAT THE TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE U.S. STATE LAWS AND REGULATIONS GOVERNING
THE OFFER AND SALE OF SECURITIES. 
  
 LUMERA CORPORATION

  
 CONVERTIBLE PROMISSORY NOTE 
  

			
	Note N-            	  	Issuance Date:                         ,
2004
	$                	  	Bothell, Washington

  
 For value received,
Lumera Corporation, a Washington corporation (the “Company”), promises to pay to
                             (the “Holder”), the principal sum of
                        . This convertible promissory note (this “Note”) is subject to the
following terms and conditions. This Note is one of a series of Convertible Promissory Notes containing substantially identical terms and conditions issued pursuant to that certain Note and Warrant Purchase Agreement dated as of April
        , 2004 (the “Note Purchase Agreement”). All notes issued under the Note Purchase Agreement are referred to herein as the “Notes,” and the holders
thereof are referred to herein as the “Holders.” 
  

	1.	Interest, Maturity and Default 

  
 (a) Interest shall accrue from the Issuance Date on the unpaid principal amount at a rate equal to 6.5 percent per annum, simple interest; provided,
however, that if any principal or interest under this Note remains unpaid after March 31, 2005 (the “Maturity Date”), the interest rate on such unpaid amounts shall increase from 6.5 percent per annum to 12 percent per annum,
simple interest. Subject to Section 2, principal and any accrued but unpaid interest under this Note shall be due and payable upon demand by the Holder at any time after the Maturity Date. 
  

 -1- 

 (b) Notwithstanding the provisions of Section 1(a) above, the entire unpaid principal sum of this Note,
together with accrued and unpaid interest thereon, shall become immediately due and payable upon (i) the execution by the Company of a general assignment for the benefit of creditors, (ii) the filing by or against the Company of a petition in
bankruptcy or any petition for relief under the federal bankruptcy act or the continuation of such petition without dismissal for a period of 90 days or more, (iii) the appointment of a receiver or trustee to take possession of the property or
assets of the Company, or (iv) the closing of an underwritten public offering of the Company’s Common Stock (defined below) pursuant to a registration statement under the Act (an “IPO”). 
  
 (c) Notwithstanding the provisions of Sections 1(a) and 1(b) above, if (i)
the Company has failed to file a registration statement (the “Registration Statement”) pursuant to Section 5.2(a) of the Note Purchase Agreement within six months of the closing of the IPO, or (ii) the Registration Statement
has not been declared effective by the Securities and Exchange Commission within 240 days of the closing of the IPO, then for each month or part thereof that the condition under this Section 1(c)(i) or 1(c)(ii) shall exist, then in addition to the
interest otherwise payable under Section 1(a), the Company shall pay to Holder a cash amount equal to 2%, or a lesser prorated amount for a period less than a month, of the unpaid or unconverted principal under this Note (the “Late
Fee”). Such Late Fee shall cease to accrue on the earliest date more than one year from the Closing Date under the Note Purchase Agreement that the Company is current in its reporting obligations under the Securities Exchange Act of
1934, as amended, and has been subject to such reporting requirements for at least 90 days. 
  

	2.	Conversion 

  

	 	(a)	Conversion at Holder’s Election 

  
 The principal and accrued but unpaid interest under this Note (the “Aggregate Note Amount”) shall, at the Holders election, be
convertible at any time into shares of (i) the Company’s Class A common stock, no par value per share (“Class A Common Stock”), or (ii) if the Class A Common Stock has been converted into another class of common stock as
of the date of conversion of the Note, the class of common stock as then authorized (the class of stock issued under this Section 2(a)(i) or (ii), the “Common Stock”). The Aggregate Note Amount shall be convertible into a
number of shares of Common Stock equal to the quotient of the Aggregate Note Amount divided by the lesser of (i) $6.00 and (ii) in the event of an IPO, the price per share of Common Stock offered to the public in the IPO (the “IPO
Price”). 
  

 -2- 

	 	(b)	Mechanics and Effect of Conversion 

  
 No fractional shares of the Company’s capital stock will be issued upon conversion of this Note. In lieu of any fractional share to which the Holder
would otherwise be entitled, the Company will pay to the Holder in cash the amount of the unconverted principal and interest balance of this Note that would otherwise be converted into such fractional share. Upon conversion of this Note pursuant to
this Section 2, the Holder shall surrender this Note, duly endorsed, at the principal offices of the Company or any transfer agent of the Company. At its expense, the Company will, as soon as practicable thereafter, issue and deliver to such Holder,
at the address of the Holder most recently furnished in writing to the Company, a certificate or certificates for the number of shares of Equity Securities to which such Holder is entitled upon such conversion, together with any other securities and
property to which the Holder is entitled upon such conversion under the terms of this Note, including a check payable to the Holder for any cash amounts payable as described herein. Upon conversion of this Note, the Company will be forever released
from all of its obligations and liabilities under this Note with regard to that portion of the principal amount and accrued interest being converted, including, without limitation, the obligation to pay such portion of the principal amount and
accrued interest. 
  

	3.	Payment 

  
 All payments shall be made in lawful money of the United States of America at such place as the Holder hereof may from time to time designate in writing
to the Company. Payment shall be credited first to the accrued interest then due and payable and the remainder applied to principal. Any amounts due in connection with this Note may be prepaid in whole or in part at any time without penalty upon ten
(10) days’ advance notice by the Company to the registered holder of this Note. 
  

	4.	Transfer; Successors and Assigns 

  
 The terms and conditions of this Note shall inure to the benefit of and be binding upon the respective successors and assigns of the parties.
Notwithstanding the foregoing, except for a pledge of this Note to a bank or other financial institution that creates a mere security interest in this Note in connection with a bona fide loan transaction, the Holder may not assign, pledge, or
otherwise transfer this Note without the prior written consent of the Company. Subject to the preceding sentence, this Note may be transferred only upon surrender of the original Note to the Company for registration of transfer, duly endorsed, or
accompanied by a duly executed written instrument of transfer in form satisfactory to the Company, and, thereupon, a new note for the same principal amount and interest will be issued to, and registered in the name 

  

 -3- 

 
of, the transferee. Interest and principal are payable only to the registered holder of this Note. 
  

	5.	Governing Law; Jurisdiction 

  
 This Note shall be governed by and construed under the laws of the State of Washington as applied to agreements among Washington residents, entered into
and to be performed entirely within the State of Washington, without giving effect to principles of conflicts of law. The parties irrevocably consent to the jurisdiction and venue of the state and federal courts located in King County, Washington in
connection with any action relating to this Note. 
  

	6.	Notices 

  
 Any notice required or permitted by this Note shall be given in writing and shall be deemed effectively given (a) upon personal delivery to the party to
be notified, (b) upon confirmation of receipt by fax by the party to be notified, (c) one business day after deposit with a reputable overnight courier, prepaid for overnight delivery and addressed as set forth in (d), or (d) three days after
deposit with the United States Post Office, postage prepaid, registered or certified with return receipt requested and addressed to the party to be notified at the address of such party indicated on the signature page hereof, or at such other
address as such party may designate by 10 days’ advance written notice to the other party given in the foregoing manner. 
  

	7.	Amendments and Waivers 

  
 Any term of this Note may be amended only with the written consent of the Company and the holders of a majority in interest of the Notes, including the
Lead Investor as set forth on Schedule 1 to the Note Purchase Agreement. Any amendment or waiver effected in accordance with this Section 7 shall be binding upon the Company, each Holder and each transferee of the Note. 
  

	8.	Shareholders, Officers and Directors Not Liable 

  
 In no event shall any shareholder, officer or director of the Company be liable for any amounts due or payable pursuant to this Note. 
  

	9.	Action to Collect on Note 

  
 If action at law or equity is necessary to enforce or interpret the terms of this Note, the prevailing party shall be entitled to reasonable
attorney’s fees, costs and 

  

 -4- 

 
necessary disbursements in addition to any other relief to which such party may be entitled. 
  

	10.	Waiver of Jury Trial 

  
 Each of the Company and Holder hereby waives its right to trial by jury in any claim (whether based upon contract, tort or otherwise) under, related to or
arising in connection with this Note. 
  

	11.	Waiver of Notice of Presentment 

  
 The Company hereby waives presentment, protest and demand, notice of protest, demand and dishonor and non-payment of this Note in connection with the
delivery, acceptance, performance, default or enforcement of the payment of this Note. 
  
 [Signature page follows.] 
  
  

 -5- 

			
	COMPANY:
	
	LUMERA CORPORATION
		
	By:	 	 
	 	 	

	 Name:
	 	 Thomas D. Mino

	 Title:
	 	 Chief Executive Officer

		
	 Address:
	 	 Lumera Corporation

	 	 	Attn: CEO
P.O. Box 3040
Bothell, WA 98041-3040
	 Facsimile:
	 	(425) 398-6501

  

			
	AGREED TO AND ACCEPTED:
	
	  

		
	By:	 	 
	 	 	

	 Name:
	 	 
	 	 	

	 Title:
	 	 
	 	 	

  

			
		
	 Address:
	 	 
	 	 	

	 	 	 
	 	 	

	 Facsimile:
	 	 
	 	 	

  
  

 EXHIBIT B 
 to 
 NOTE PURCHASE AGREEMENT 
  
 FORM OF COMMON STOCK WARRANT 
  

NEITHER THE SECURITIES REPRESENTED HEREBY NOR THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE “SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE COMPANY THAT SUCH SECURITIES MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED ONLY (A) TO THE COMPANY, (B) PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT, (C) IN ACCORDANCE WITH RULE 144, RULE 145 OR RULE 144A UNDER THE SECURITIES ACT, IF APPLICABLE, AND IN ACCORDANCE WITH ANY APPLICABLE STATE SECURITIES OR “BLUE SKY” LAWS OR (D) IF THE COMPANY HAS RECEIVED
AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY, OR OTHERWISE SATISFIED ITSELF, THAT THE TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE U.S. STATE LAWS AND REGULATIONS GOVERNING THE OFFER AND SALE
OF SECURITIES. 
  

			
	 No. W – __
 Issued Effective: _________,
2004
 Void After: _________, 2009
	 	Warrant to Purchase Shares of
Common Stock

  
 LUMERA CORPORATION

  
 COMMON STOCK WARRANT 
  
 THIS IS TO CERTIFY that, for value received and subject to these terms and
conditions,                         , or such person to whom this Warrant is transferred (the
“Holder”), is entitled, subject to the provisions hereof, to exercise this Warrant to purchase from Lumera Corporation, a Washington corporation (the “Company”), up to that number of fully paid and
nonassessable shares of the Company’s Common Stock (collectively, the “Warrant Stock”) equal to the quotient of (a) 0.30 multiplied by
$                , divided by (b) the lesser of $6.00 and the per share price of the Company’s Common Stock offered to the public pursuant to a registration
statement under the Securities Act of 1933, as amended, in the company’s initial public offering (such per share price to the public in the initial public offering, the “IPO Price”), at an exercise price per share equal
to the lesser of (x) $7.20 per share and (y) the product of 1.2 multiplied by the IPO Price (such lesser price, the “Exercise Price”), such number of shares and the Exercise Price being subject to adjustment as provided
below. For purposes of this Warrant, “Common Stock” means the Company’s Class A common stock, no par value per share, or, if such Class A Common Stock has been converted into another class of common stock, the class of
common stock as then authorized. 
  

	1.	Exercise 

  

	 	1.1	Exercisability 

  
 This Warrant shall be exercisable in full for the number of shares of Warrant Stock under this Warrant (the “Eligible Shares”)
during the period from the date of issuance of this Warrant to the fifth anniversary of the date of issuance of this Warrant; provided, however, that this Warrant shall not be exercisable during the period from the date the Company files a
registration statement for an initial public offering of Common Stock of the Company (other than a registration statement relating either to the sale of securities to employees of the Company pursuant to a stock option, stock purchase or similar
plan approved by the Board of Directors of the Company or a transaction under Rule 145 as promulgated by the Securities and Exchange Commission and approved by the Board of Directors of the Company) (an “IPO Filing”), to the
earlier of the date (a) six months after the closing of the public offering undertaken in connection with the IPO Filing and (b) the first anniversary of the date of the IPO Filing. The periods during which this Warrant may be exercised under the
foregoing sentence are defined as the “Exercisability Periods.” 
  

	 	1.2	Exercise 

  
 (a) This Warrant may be exercised by the Holder at any time during the Exercisability Periods; provided, however, that in the event of (1) the sale of all
or substantially all the assets of the Company to an entity other than Microvision, Inc. (“Microvision”), or (2) the closing of the acquisition of the Company by an entity other than Microvision by means of merger,
consolidation or other transaction or series of related transactions which results in the shareholders of the Company prior to such transaction not owning, directly or indirectly, at least 50% of the voting power of the surviving entity (or its
parent), this Warrant shall, on the date of such event, no longer be exercisable and become null and void. In the event of a proposed transaction of the kind described in this Section 1.2(a), the Company shall notify the holder of the Warrant at
least 20 days prior to the consummation of such event or transaction. 
  
 (b) Subject to the provisions of Section 1.1 and Section 1.2(a), this Warrant may be exercised, in whole or in part, by delivering to the Company at the address set forth in Section 9.3 hereof (or such other office or agency of the Company
as it may designate by notice in writing to the Holder at the address of the Holder appearing on the books of the Company) (1) this Warrant certificate, (2) a certified or cashier’s check payable to the Company, or canceled indebtedness of the
Company to the Holder, in the amount of the Exercise Price multiplied by the number of shares for which this Warrant is being exercised (the “Purchase Price”), and (3) the Notice of 

  

 -2- 

 
Cash Exercise attached as Exhibit A duly completed and executed by the Holder. Upon exercise, the Holder shall be entitled to receive from the
Company a stock certificate in proper form representing the number of Eligible Shares of Warrant Stock purchased. 
  
 (c) (1) Subject to the Exercisability Periods set forth in Section 1.1 above, and notwithstanding the payment provisions set forth in Section 1.2(b)
above, if at any time after one year has elapsed from the date of issuance of this Warrant the Company does not have available both an effective Registration Statement as provided under Section 5.2 of the Note Purchase Agreement and a current
prospectus covering the Eligible Shares hereunder, the Holder may elect to convert all or any portion of this Warrant into Eligible Shares of Warrant Stock effective upon delivery to the Company of the Notice of Net Issuance Exercise attached as
Exhibit B duly completed and executed by the Holder, provided that the original of this Warrant is surrendered at the office of the Company at the address set forth in Section 9.3 within five (5) days of the delivery of such Notice of
Net Issuance, in which case the Company shall issue to the Holder the number of Eligible Shares of Warrant Stock of the Company equal to the result obtained by (A) subtracting B from A, (B) multiplying the difference by C, and (C) dividing the
product by A as set forth in the following equation: 
  
 X = (A
- B) x C:         
 A 
  

							
	 where:
	  	X	  	=	  	the number of Eligible Shares of Warrant Stock issuable upon net issuance exercise pursuant to the provisions of this Section 1.2(c).
				
	 	  	A	  	=	  	the Fair Market Value (as defined below) of one share of Warrant Stock on the date of net issuance exercise.
				
	 	  	B	  	=	  	the Exercise Price for one share of Warrant Stock under this Warrant.
				
	 	  	C	  	=	  	the number of Eligible Shares of Warrant Stock as to which this Warrant is being exercised.

  
 If the foregoing
calculation results in a negative number, then no shares of Warrant Stock shall be issued upon net issuance exercise pursuant to this Section 1.2(c). 
  

 -3- 

 (2) For purposes of the foregoing, the “Fair Market Value” of a share of Warrant
Stock shall mean: 
  
 (A) if the net issuance
exercise is after the occurrence of the initial public offering of the Company’s Common Stock: 
  
 (i) if the Company’s Common Stock is traded on an exchange or is quoted on the Nasdaq National or SmallCap Market, the average of the
closing or last sale price reported for each of the three business days immediately preceding the date of net issuance exercise multiplied by the number of shares of Common Stock; 
  
 (ii) if the Company’s Common Stock is not traded on an exchange or on the Nasdaq National or SmallCap
Market, but is traded in the over-the-counter market, the average of the closing bid prices reported at 4:00 pm Eastern time by Bloomberg Financial News for the five market days immediately preceding the date of net issuance exercise; and

  
 (B) in all other cases, the fair value as
determined in good faith by the Company’s Board of Directors. 
  
 (3) Upon net issuance exercise in accordance with this Section 1.2(c), the Holder shall be entitled to receive from the Company a stock certificate in proper form representing the number of Eligible Shares of Warrant Stock determined in
accordance with the foregoing. 
  

	2.	Stock Certificates and Warrants 

  
 Within ten days after the payment of the Purchase Price following the exercise of this Warrant (in whole or in part) or the satisfaction of the net
exercise provisions of Section 1.2(c) of this Warrant, the Company at its expense shall issue in the name of and deliver to the Holder (a) a certificate or certificates for the number of fully paid and nonassessable shares of Warrant Stock to which
the Holder shall be entitled upon such exercise, and (b) a new Warrant of like tenor to purchase up to that number of shares of Warrant Stock, if any, as to which this Warrant has not been exercised if this Warrant has not expired. The Holder shall
for all purposes be deemed to have become the holder of record of such shares of Warrant Stock on the date this Warrant was exercised (the date the Holder has fully complied with the requirements of Section 1.2), irrespective of the date of delivery
of the certificate or certificates representing the Warrant Stock; provided that, if the date such exercise is made is a date when the stock transfer books of the Company are closed, such person shall be deemed to have become the holder of record of
such shares of Warrant Stock at the close of business on the next succeeding date on which the stock transfer books are 

  

 -4- 

 
open. No fractional shares shall be issued upon the exercise of this Warrant. In lieu of fractional shares, the Company shall pay the Holder a sum in cash
equal to the fair market value of such fractional share on the date of exercise. 
  

	3.	Covenants as to Warrant Stock 

  
 The Company covenants that at all times during the Exercise Period there shall be reserved for issuance and delivery upon exercise of this Warrant such
number of shares of Common Stock as is necessary for exercise in full of this Warrant and, from time to time, it will take all steps necessary to amend its Articles of Incorporation to provide sufficient reserves of shares of Common Stock. All
shares of Warrant Stock issued pursuant to the exercise of this Warrant will, upon their issuance, be validly issued and outstanding, fully paid and nonassessable, free and clear of all liens and other encumbrances or restrictions on sale, and free
and clear of all preemptive rights, except restrictions arising under federal and state securities laws. 
  

	4.	Adjustments 

  

	 	4.1	Adjustments for Stock Splits, Dividends 

  
 If the Company shall issue any shares of the same class as the Warrant Stock as a stock dividend or subdivide the number of outstanding shares of such
class into a greater number of shares, then, in either such case, the Exercise Price in effect before such dividend or subdivision shall be proportionately reduced and the number of shares of Warrant Stock at that time issuable pursuant to the
exercise of this Warrant shall be proportionately increased; and, conversely, if the Company shall contract the number of outstanding shares of the same class as the Warrant Stock by combining such shares into a smaller number of shares, then the
Exercise Price in effect before such combination shall be proportionately increased and the number of shares of Warrant Stock at that time issuable pursuant to the exercise or conversion of this Warrant shall be proportionately decreased. Each
adjustment in the number of shares of Warrant Stock issuable shall be to the nearest whole share. 
  

	 	4.2	Certificate as to Adjustments 

  
 In the case of any adjustment in the Exercise Price or number of securities issuable upon exercise of this Warrant, the Company will promptly give written
notice to the Holder in the form of a certificate, certified and confirmed by the chief executive officer of the Company, setting forth the adjustment in reasonable detail. 
  

 -5- 

	5.	Securities Laws Restrictions; Legend on Warrant Stock 

  
 5.1 This Warrant and the securities issuable upon its exercise have not been registered under the Securities Act of 1933, as amended (the
“Act”), or applicable state securities laws, and no interest may be sold, distributed, assigned, offered, pledged or otherwise transferred unless (a) there is an effective registration statement under the Act and applicable
state securities laws covering any such transaction involving said securities, (b) the Company receives an opinion of legal counsel for the holder of the securities satisfactory to the Company stating that such transaction is exempt from
registration, or (c) the Company otherwise satisfies itself that such transaction is exempt from registration, provided that none of the restrictions hereunder shall restrict any pledge of this Warrant and the securities issuable upon its exercise
to a bank or other financial institution that creates a mere security interest in such Warrant and securities in connection with a bona fide loan transaction. 
  

5.2 A legend setting forth or referring to the above restrictions shall be placed on this Warrant, any replacement warrant and any certificate
representing the Warrant Stock, and a stop transfer order shall be placed on the books of the Company and with any transfer agent until such securities may be legally sold or otherwise transferred. 
  

	6.	Exchange of Warrant; Lost or Damaged Warrant Certificate 

  
 This Warrant is exchangeable upon its surrender by the Holder at the office of the Company. Upon receipt by the Company of satisfactory evidence of the
loss, theft, destruction or damage of this Warrant and either (in the case of loss, theft or destruction) reasonable indemnification or (in the case of damage) the surrender of this Warrant for cancellation, the Company will execute and deliver to
the Holder, without charge, a new Warrant of like denomination. 
  

	7.	Notices of Record Date, Etc. 

  
 In the event of: 
  
 (a) any taking by the Company of a record of the holders of Warrant Stock for the purpose of determining the holders who are entitled to receive any
dividend or other distribution, or any right to subscribe for, purchase or otherwise acquire any shares of stock of any class or any other securities or property, or to receive any other right; 
  
 (b) any reorganization of the Company, any reclassification or
recapitalization of the capital stock of the Company, or any transfer of all or 

  

 -6- 

 
substantially all the assets, property or stock of the Company to, or consolidation or merger of, the Company with or into any other entity; 
  
 (c) any voluntary or involuntary dissolution, liquidation or winding-up of
the Company; 
  
 (d) the initial public offering of the
Company’s Common Stock; or 
  
 (e) any other event as to
which the Company is required to give notice to all holders of Warrant Stock, 
  
 then and, in each such event, the Company will deliver to the Holder a notice specifying (i) the date on which any such record is to be taken, (ii) the date on which any such reorganization, reclassification, recapitalization, transfer,
consolidation, merger, dissolution, liquidation or winding-up is to take place, and the time, if any is to be fixed, as to which the holders of record of Warrant Stock shall be entitled to exchange their shares for securities or other property
deliverable on such reorganization, reclassification, recapitalization, transfer, consolidation, merger, dissolution, liquidation or winding-up, and (iii) in reasonable detail, the facts, including the proposed date, concerning any other such event.
Such notice shall be delivered to the Holder at least 20 business days prior to the date specified in the notice. 
  

	8.	Investment Intent 

  
 By accepting this Warrant, the Holder represents that it is acquiring this Warrant for investment and not with a view to, or for sale in connection with,
any distribution thereof. 
  

	9.	Miscellaneous 

  

	 	9.1	Holder as Owner 

  
 The Company may deem and treat the Holder of record of this Warrant as the absolute owner for all purposes regardless of any notice to the contrary.

  

	 	9.2	No Shareholder Rights 

  
 This Warrant shall not entitle the Holder to any voting rights or any other rights as a shareholder of the Company or to any other rights except the
rights stated herein, and no cash dividend or interest shall be payable or shall accrue in respect of this Warrant or the Warrant Stock until this Warrant is exercised. 
  

 -7- 

	 	9.3	Notices 

  
 Unless otherwise provided, any notice under this Warrant shall be given in writing and shall be deemed effectively given (a) upon personal delivery to the
party to be notified, (b) upon confirmation of receipt by fax by the party to be notified, (c) one business day after deposit with a reputable overnight courier, prepaid for overnight delivery and addressed as set forth in (d), or (d) five days
after deposit with the United States Post Office, postage prepaid, registered or certified with return receipt requested and addressed to the party to be notified at the address indicated below, or at such other address as such party may designate
by ten days’ advance written notice to the other party given in the foregoing manner. 
  

			
	 If to the Holder:
	  	 _____________________
 _____________________
 _____________________

		
	 If to the Company:
	  	 LUMERA CORPORATION
 PO Box 3040
 Bothell, WA 98041-3040
 Attn: Chief Executive Officer

  

	 	9.4	Amendments and Waivers 

  
 Any term of this Warrant may be amended and the observance of any term may be waived (either generally or in a particular instance and either
retroactively or prospectively) only with the written consent of the Company and the Holder. Any amendment or waiver effected in accordance with this Section 9.4 shall be binding on each future Holder and the Company. 
  

	 	9.5	Governing Law; Jurisdiction 

  
 This Warrant shall be governed by and construed under the laws of the State of Washington as applied to agreements among Washington residents, entered
into and to be performed entirely within the State of Washington, without giving effect to principles of conflicts of law. The parties irrevocably consent to the jurisdiction and venue of the state and federal courts located in King County,
Washington in connection with any action relating to this Warrant. 
  

 -8- 

	 	9.6	Successors and Assigns; Transfer 

  
 The terms and conditions of this Warrant shall inure to the benefit of and be binding on the parties and their respective successors and assigns.
Notwithstanding the foregoing, this Warrant shall not be assignable or transferable without the prior written consent of the Company. 
  
 IN WITNESS WHEREOF, the Company has executed this Warrant as of the date first above written. 
  

			
	LUMERA CORPORATION
		
	By:	 	 
	 	 	

	 	 	 Thomas D. Mino
 Chief Executive Officer

  

 -9- 

 Exhibit A 
  
 NOTICE OF CASH EXERCISE 
  

	To:	Lumera Corporation 

  
 The undersigned hereby irrevocably elects to purchase
                     shares of Common Stock of Lumera Corporation. (the “Company”) issuable upon the exercise of the
attached Warrant and requests that certificates for such shares be issued in the name of and delivered to the address of the undersigned, at the address stated below and, if said number of shares shall not be all the shares that may be purchased
pursuant to the attached Warrant, that a new Warrant of like tenor evidencing the right to purchase the balance of such shares be registered in the name of, and delivered to, the undersigned at the address stated below. The undersigned agrees with
and represents to the Company that (i) said shares of the Common Stock of the Company are acquired for the account of the undersigned for investment and not with a view to, or for sale in connection with, any distribution or public offering within
the meaning of the Securities Act of 1933, as amended, and (ii) the undersigned is an “accredited investor” as defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended. 
  

					
	 Dated:
                    
	 	 	 	 
			
	  	 	 	 	 Payment enclosed in the amount of
$                    .

			
	  	 	 	 	 Company Debt canceled in the amount of
$                    .

			
	  	 	 	 	 Name of Holder: 

			
	  	 	 	 	  
	 	 	 	 	

	  	 	 	 	 (please print)

			
	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	 (Signature)

			
	 	 	 	 	 Address:

	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	 
	 	 	 	 	

  

 Exhibit B 
  
 NOTICE OF NET ISSUANCE EXERCISE 
  

	To:	Lumera Corporation 

  
 The undersigned hereby irrevocably elects to exercise the attached Warrant to convert the number of shares specified below into such number of shares of
Common Stock of Lumera Corporation (the “Company”) as is determined pursuant to Section 1.2(c) of the attached Warrant. The undersigned requests that certificates for such net issuance shares be issued in the name of and
delivered to the address of the undersigned and, if said number of shares shall not be all the shares that may be purchased pursuant to the attached Warrant, that a new Warrant of like tenor evidencing the right to purchase the balance of such
shares be registered in the name of, and delivered to, the undersigned at the address stated below. The undersigned agrees with and represents to the Company that (i) said shares of Common Stock of the Company are acquired for the account of the
undersigned for investment and not with a view to, or for sale in connection with, any distribution or public offering within the meaning of the Securities Act of 1933, as amended, and (ii) the undersigned is an “accredited investor” as
defined in Rule 501(a) of Regulation D promulgated under the Securities Act of 1933, as amended. 
  

					
	 Dated:
                    
	 	 	 	 
			
	  	 	 	 	 Number of Shares Being Exercised:

			
	  	 	 	 	  
	 	 	 	 	

			
	  	 	 	 	 Name of Holder of Warrant:

			
	  	 	 	 	  
	 	 	 	 	

	  	 	 	 	 (please print)

			
	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	 (Signature)

			
	 	 	 	 	 Address:

	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	 
	 	 	 	 	

  

 ASSIGNMENT 
  
 For value received, the undersigned sells, assigns and transfers to the transferee named below the attached Warrant,
together with all right, title and interest, and does irrevocably constitute and appoint the transfer agent of Lumera Corporation (the “Company”) as the undersigned’s attorney, to transfer said Warrant on the books of
the Company, with full power of substitution in the premises. 
  

					
	 Dated:
                    
	 	 	 	 
			
	  	 	 	 	 Name of Holder:

			
	  	 	 	 	  
	 	 	 	 	

	  	 	 	 	 (please print)

			
	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	 (Signature)

			
	 	 	 	 	 Address:

	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	 
	 	 	 	 	

			
	  	 	 	 	 Name of Transferee:

			
	  	 	 	 	  
	 	 	 	 	

	  	 	 	 	 (please print)

			
	 	 	 	 	 Address:

	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	 
	 	 	 	 	

	 	 	 	 	 
	 	 	 	 	

  

 -2-Amended and Restated Investors' Rights Agreement dated August 25, 2004

 Exhibit 10.16 
  
 LUMERA CORPORATION 
  
 AMENDED AND RESTATED 
  
 INVESTORS’ RIGHTS AGREEMENT 
  
 First Closing: August 25, 2003 
  
 Second Closing: October 30, 2003 
  

 TABLE OF CONTENTS 
  

							
	 	  	 	  	 	  	Page

	 1.
	  	Registration Rights	  	2
				
	 	  	1.1	  	 Definitions
	  	2
	 	  	1.2	  	 Request for Registration
	  	3
	 	  	1.3	  	 Company Registration
	  	4
	 	  	1.4	  	 Form S-3 Registration
	  	5
	 	  	1.5	  	 Obligations of the Company
	  	6
	 	  	1.6	  	 Furnish Information
	  	7
	 	  	1.7	  	 Expenses of Registration
	  	7
	 	  	1.8	  	 Underwriting Requirements
	  	8
	 	  	1.9	  	 Delay of Registration
	  	9
	 	  	1.10	  	 Indemnification
	  	9
	 	  	1.11	  	 Reports Under Securities Exchange Act of 1934
	  	11
	 	  	1.12	  	 Assignment of Registration Rights
	  	12
	 	  	1.13	  	 Limitations on Subsequent Registration Rights
	  	12
	 	  	1.14	  	 Market Stand-Off Agreement
	  	13
	 	  	1.15	  	 Termination of Registration Rights
	  	13
			
	 2.
	  	Covenants of the Company	  	14
				
	 	  	2.1	  	 Delivery of Financial Statements
	  	14
	 	  	2.2	  	 Inspection
	  	14
	 	  	2.3	  	 Right of Participation
	  	14
	 	  	2.4	  	 Stock Vesting
	  	16
	 	  	2.5	  	 Employee Non-Disclosure and Assignment of Inventions Agreement
	  	16
	 	  	2.7	  	 Termination of Covenants
	  	16
			
	 3.
	  	Miscellaneous	  	16
				
	 	  	3.1	  	 Successors and Assigns
	  	16
	 	  	3.2	  	 Amendments and Waivers
	  	17
	 	  	3.3	  	 Notices
	  	17
	 	  	3.4	  	 Severability
	  	17
	 	  	3.5	  	 Governing Law
	  	17
	 	  	3.6	  	 Counterparts
	  	17
	 	  	3.7	  	 Titles and Subtitles
	  	17
	 	  	3.8	  	 Aggregation of Stock
	  	17
	 	  	3.9	  	 Specific Enforcement
	  	18

  

 LUMERA CORPORATION 
  
 AMENDED AND RESTATED 
  

INVESTORS’ RIGHTS AGREEMENT 
  
 This Amended and Restated Investors’ Rights Agreement (the “Agreement”) is made as of the 25th day of August, 2003, by and among Lumera Corporation, a Washington corporation (the “Company”) and the investors listed on
Exhibit A hereto, each of which is herein referred to as an “Investor.” 
  
 RECITALS 
  
 WHEREAS, the Company and certain Investors have previously entered into an Investors’ Rights Agreement dated March 14, 2001 (the “Prior Rights Agreement”), pursuant to which the Company granted the holders of
Series A Preferred Stock certain rights; 
  
 WHEREAS, the
Company and certain Investors have entered into a Series B Preferred Stock Purchase Agreement (the “Purchase Agreement”) of even date herewith pursuant to which the Company desires to sell to such Investors and such Investors desire
to purchase from the Company shares of the Company’s Series B Preferred Stock; 
  
 WHEREAS, a condition to the Investors’ obligations under the Purchase Agreement is that the Company and the Investors enter into this Agreement in order to provide the Investors with (i) certain rights to
register shares of the Company’s Class A Common Stock issuable upon conversion of the Series B Preferred Stock held by the Investors, (ii) certain rights to receive or inspect information pertaining to the Company, and (iii) a right of
participation with respect to certain issuances by the Company of its securities; and 
  
 WHEREAS, the Company and the holders of Series A Preferred Stock desire to induce certain of the Investors to purchase shares of Series B Preferred Stock pursuant to the Purchase Agreement by agreeing to the
terms and conditions set forth herein and amend and restate the Prior Rights Agreement. 
  

 NOW, THEREFORE, in consideration of the mutual promises, representations, warranties, covenants
and conditions set forth in this Agreement and in the Purchase Agreement, the parties hereto agree to amend and restate the Prior Rights Agreement as follows: 
  

1. Registration Rights. The Company and the Investors covenant and agree as follows: 
  
 1.1 Definitions. For purposes of this Section 1: 
  
 (a) The terms “register,”
“registered,” and “registration” refer to a registration effected by preparing and filing a registration statement or similar document in compliance with the Securities Act of 1933, as amended (the
“Securities Act”), and the declaration or ordering of effectiveness of such registration statement or document; 
  
 (b) The term “Registrable Securities” means (i) the shares of Class A Common Stock issuable or issued upon conversion of
the Series A Preferred Stock or Series B Preferred Stock and (ii) any other shares of Class A Common Stock of the Company issued as (or issuable upon the conversion or exercise of any warrant, right or other security which is issued as) a dividend
or other distribution with respect to, or in exchange for or in replacement of, the shares listed in (i); provided, however, that the foregoing definition shall exclude in all cases any Registrable Securities sold by a person in a transaction in
which his or her rights under this Agreement are not assigned. Notwithstanding the foregoing, Class A Common Stock or other securities shall only be treated as Registrable Securities if and so long as they have not been (A) sold to or through a
broker or dealer or underwriter in a public distribution or a public securities transaction, or (B) sold in a transaction exempt from the registration and prospectus delivery requirements of the Securities Act under Section 4(1) thereof or Rule 144
thereunder so that all transfer restrictions, and restrictive legends with respect thereto, if any, are removed upon the consummation of such sale; 
  
 (c) The number of shares of “Registrable Securities then outstanding” shall be determined by the number of shares of
Class A Common Stock outstanding which are, and the number of shares of Class A Common Stock issuable pursuant to then exercisable or convertible securities which are, Registrable Securities; 
  
 (d) The term “Holder” means any person
owning or having the right to acquire Registrable Securities or any assignee thereof in accordance with Section 1.12 of this Agreement; 
  
 (e) The term “Form S-3” means such form under the Securities Act as in effect on the date hereof or any successor form
under the Securities Act; 
  
 (f) The term
“SEC” means the Securities and Exchange Commission; and 
  
 (g) The term “Qualified IPO” means a firm commitment underwritten public offering by the Company of shares of its Common Stock pursuant to a registration statement under the Securities Act, with a
public offering price per share of not less than $2 and which results in aggregate cash proceeds to the Company of an amount equal to or greater than $10,000,000 (net of underwriting discounts and commissions). 
  

 -2- 

 1.2 Request for Registration. 
  
 (a) If the Company shall receive at any time after the
earlier of (i) May          , 2006 or (ii) six (6) months after the effective date of the first registration statement for a public offering of securities of the Company (other than a registration
statement relating either to the sale of securities to employees of the Company pursuant to a stock option, stock purchase or similar plan approved by the Board of Directors of the Company or an SEC Rule 145 transaction approved by the Board of
Directors of the Company), a written request from the Holders of at least 30% of the Registrable Securities then outstanding that the Company file a registration statement under the Securities Act covering the registration of not less than 30% of
the Registrable Securities then outstanding with an anticipated aggregate gross offering price of at least $10,000,000, then the Company shall, within ten (10) days of the receipt thereof, give written notice of such request to all Holders and
shall, subject to the limitations of subsection 1.2(b), use reasonable efforts to effect as soon as practicable, and in any event within 90 days of the receipt of such request, the registration under the Securities Act of all Registrable Securities
which the Holders request to be registered within fifteen (15) days of the mailing of such notice by the Company in accordance with Section 3.3. Subject to the limitations of this Section 1.2, the Company may also include shares of its capital stock
in such registration. 
  
 (b) If the Holders
initiating the registration request hereunder (“Initiating Holders”) intend to distribute the Registrable Securities covered by their request by means of an underwriting, they shall so advise the Company as a part of their request
made pursuant to this Section 1.2 and the Company shall include such information in the written notice referred to in subsection 1.2(a). The underwriter will be selected by a majority in interest of the Initiating Holders and shall be reasonably
acceptable to the Company. In such event, the right of any Holder to include his Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s
Registrable Securities in the underwriting (unless otherwise mutually agreed by a majority in interest of the Initiating Holders and such Holder) to the extent provided herein. All Holders proposing to distribute their securities through such
underwriting shall (together with the Company as provided in subsection 1.5(e)) enter into an underwriting agreement in customary form with the underwriter or underwriters selected for such underwriting. Notwithstanding any other provision of this
Section 1.2, if the underwriter advises the Initiating Holders in writing that marketing factors require a limitation of the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities which
would otherwise be underwritten pursuant hereto, and the number of shares of Registrable Securities that may be included in the underwriting shall be allocated among all Holders thereof, including the Initiating Holders, in proportion (as nearly as
practicable) to the amount of Registrable Securities of the Company owned by each Holder; provided, however, that the number of shares of Registrable Securities to be included in such underwriting shall not be reduced unless all other
securities are first entirely excluded from the underwriting; provided, further, that notwithstanding the foregoing, if the University of Washington (the “University”) requests pursuant to the Restricted Stock Purchase
Agreement dated October 20, 2000 between the University and the Company to include in a registration pursuant to this Section 1.2 shares of the Company’s Class A Common Stock held by 

  

 -3- 

 
the University (the “UW Shares”), the number of securities to be registered in such registration shall be allocated to each Holder and the
University in proportion (as nearly as practicable) to the amount of the Company’s securities held by each Holder exercising its rights hereunder and the University, provided that the number of UW Shares is not reduced below twenty
percent (20%) of the number of securities to be registered in such registration, unless such registration is the Company’s initial public offering. 
  
 (c) Notwithstanding the foregoing, if the Company shall furnish to Holders requesting a registration statement pursuant to this Section
1.2, a certificate signed by the President of the Company stating that in the good faith judgment of the Board of Directors of the Company, the filing would interfere with a material financing, corporate reorganization, acquisition, merger,
consolidation or other material fact or event, the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders; provided, however, that the Company may not
utilize this right more than once in any twelve-month period. 
  
 (d) In addition, the Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to this Section 1.2: 
  
 (i) After the Company has effected two (2) registrations pursuant to this Section 1.2 and such registrations
have been declared or ordered effective; 
  
 (ii)
During the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of filing of, and ending on a date one hundred eighty (180) days after the effective date of, a registration subject to Section 1.3
hereof; provided that the Company is in good faith using reasonable efforts to cause such registration statement to become effective; or 
  
 (iii) If the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered on Form S-3
pursuant to a request made pursuant to Section 1.4 below. 
  
 1.3
Company Registration. After the Company’s initial public offering, if (but without any obligation to do so) the Company proposes to register (including for this purpose a registration effected by the Company for shareholders other than the Holders) any of its stock under the Securities Act in connection with the public
offering of such securities solely for cash (other than a registration relating solely to the sale of securities to participants in a Company stock plan approved by the Board of Directors of the Company or a transaction covered by Rule 145 under the
Securities Act approved by the Board of Directors of the Company, a registration in which the only stock being registered is Common Stock issuable upon conversion of debt securities which are also being registered, or any registration on any form
which does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities), the Company shall, at such time, promptly give each Holder written notice of
such registration. Upon the written request of each Holder given within twenty (20) days after mailing of such notice by the Company in accordance 

  

 -4- 

 
with Section 3.3, the Company shall, subject to the provisions of Section 1.8, cause to be registered under the Securities Act all of the Registrable
Securities that each such Holder has requested to be registered. If a Holder decides not to include any or all of its Registrable Securities in any registration statement filed by the Company, such holder shall nevertheless continue to have the
right to include any Registrable Securities in any subsequent registration statement or statements as may be filed by the Company with respect to offerings of its securities, all upon the terms and conditions set forth herein. 
  
 1.4 Form S-3 Registration. In case the Company shall receive
from any Holder or Holders a written request or requests that the Company effect a registration on Form S-3, with an anticipated aggregate gross offering price of not less than $2,000,000, and any related qualification or compliance with respect to
all or a part of the Registrable Securities owned by such Holder or Holders, the Company will: 
  
 (a) promptly give written notice of the proposed registration, and any, related qualification or compliance, to all other Holders; and

  
 (b) as soon as practicable, effect such
registration, up to one (1) per year, and all such qualifications and compliances as may be so requested and as would permit or facilitate the sale and distribution of all or such portion of such Holder’s or Holders’ Registrable Securities
as are specified in such request, together with all or such portion of the Registrable Securities of any other Holder or Holders joining in such request as are specified in a written request given within twenty (20) days after receipt of such
written notice from the Company; provided, however, that the Company shall not be obligated to effect any such registration, qualification or compliance, pursuant to this Section 1.4: (i) if Form S-3 is not available for such offering by the
Holders; (ii) if the Holders, together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate gross price to the
public of less than $2,000,000; (iii) if the Company shall furnish to the Holders a certificate signed by the President of the Company stating that in the good faith judgment of the Board of Directors of the Company, the filing would interfere with
a material financing, corporate reorganization, acquisition, merger, consolidation or other material fact or event, in which event the Company shall have the right to defer the filing of the Form S-3 registration statement for a period of not more
than 90 days after receipt of the request of the Holder or Holders under this Section 1.4; provided, however, that the Company shall not utilize this right more than once in any twelve month period; (iv) if the Company has, within the
twelve (12) month period preceding the date of such request, already effected one registration on Form S-3 for the Holders pursuant to this Section 1.4; (v) in any particular jurisdiction in which the Company would be required to qualify to do
business or to execute a general consent to service of process in effecting such registration, qualification or compliance, and in which the Company is not already qualified to do business or subject to service of process; or (vi) during the period
ending one hundred eighty (180) days after the effective date of (x) a registration statement filed pursuant to Section 1.2 or a registration statement subject to Section 1.3 or (y) the registration statement for the Company’s initial public
offering. 
  

 -5- 

 (c) Subject to the foregoing, the Company shall file a registration statement covering
the Registrable Securities and other securities so requested to be registered as soon as practicable after receipt of the request or requests of the Holders. Registrations effected pursuant to this Section 1.4 shall not be counted as demands for
registration or registrations effected pursuant to Sections 1.2 or 1.3, respectively. 
  
 1.5 Obligations of the Company. Whenever required under this Section 1 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible:

  
 (a) Prepare and file with the SEC a
registration statement with respect to such Registrable Securities and use reasonable efforts to cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered
thereunder, keep such registration statement effective for up to ninety (90) days. The Company shall not be required to file, cause to become effective or maintain the effectiveness of any registration statement that contemplates a distribution of
securities on a delayed or continuous basis pursuant to Rule 415 under the Securities Act, except for registrations pursuant to Section 1.4; provided, however, that the Company will only be required to keep such registration statement
effective for up to ninety (90) days. 
  
 (b)
Prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect
to the disposition of all securities covered by such registration statement for up to ninety (90) days. 
  
 (c) Furnish to the Holders such numbers of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements
of the Securities Act, and such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them. 
  

(d) Use reasonable efforts to register and qualify the securities covered by such registration statement under such other securities or
Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders, provided that the Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service
of process in any such states of jurisdictions, and in which the Company is not already qualified to do business or subject to service of process. 
  
 (e) In the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and
customary form, with the managing underwriter of such offering. Each Holder participating in such underwriting shall also enter into and perform its obligations under such an agreement. 
  
 (f) Notify each Holder of Registrable Securities covered by such registration statement at any time when a
prospectus relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such 

  

 -6- 

 
registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or
necessary to make the statements therein not misleading in the light of the circumstances then existing, such obligation to continue for ninety (90) days. 
  
 (g) Cause all such Registrable Securities registered pursuant hereunder to be listed on each securities exchange or over-the-counter
market on which similar securities issued by the Company are then listed. 
  
 (h) Provide a transfer agent and registrar for all Registrable Securities registered pursuant hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such
registration. 
  
 (i) Use reasonable efforts to
furnish, at the request of any Holder requesting registration of Registrable Securities pursuant to this Section 1, on the date that such Registrable Securities are delivered to the underwriters for sale in connection with a registration pursuant to
this Section 1, being sold through underwriters, (i) an opinion, dated such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters in an underwritten public
offering, addressed to the underwriters, and to the Holders requesting registration of Registrable Securities and (ii) a letter dated such date, from the independent certified public accountants of the Company, in form and substance as is
customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters and to the Holders requesting registration of Registrable Securities. 
  
 1.6 Furnish Information. It shall be a condition precedent to
the obligations of the Company to take any action pursuant to this Section 1 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities
held by it, and the intended method of disposition of such securities as shall be required to effect the registration of such Holder’s Registrable Securities. The Company shall have no obligation with respect to any registration requested
pursuant to Section 1.2 or Section 1.4 of this Agreement if, as a result of the application of the preceding sentence, the number of shares or the anticipated aggregate offering price of the Registrable Securities to be included in the registration
does not equal or exceed the number of shares or the anticipated aggregate offering price required to originally trigger the Company’s obligation to initiate such registration as specified in subsection 1.2(a) or Section 1.4, whichever is
applicable. • 
  
 1.7 Expenses of Registration.

  
 (a) Demand Registration.
All expenses other than underwriting discounts and commissions incurred in connection with registrations, filings or qualifications pursuant to Section 1.2, including (without limitation) all registration, filing and qualification fees,
printers’ and accounting fees, fees and disbursements of counsel for the Company, and the reasonable and documented fees and disbursements of one counsel for the selling Holders selected by them not to exceed $15,000 shall be borne by the
Company; provided, however, that the Company shall 

  

 -7- 

 
not be required to pay for any expenses of any registration proceeding begun pursuant to Section 1.2 if the registration request is subsequently withdrawn at
the request of the Holders of a majority of the Registrable Securities to be registered and the Company is in compliance with this Agreement (in which case all participating Holders shall bear all such reasonable expenses in proportion to the number
of shares for which registration was requested), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one demand registration pursuant to Section 1.2; provided further, however, that if at the time of such
withdrawal, the Holders have learned of a material adverse change in the condition, results, business, or prospects of the Company that would adversely affect the offering and have withdrawn the request with reasonable promptness following
disclosure by the Company of such material adverse change, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Section 1.2. 
  
 (b) Company Registration. All expenses other than underwriting discounts and
commissions incurred in connection with registrations, filings or qualifications of Registrable Securities pursuant to Section 1.3 for each Holder, including (without limitation) all registration, filing, and qualification fees, printers’ and
accounting fees, fees and disbursements of counsel for the Company and the reasonable and documented fees and disbursements of one counsel for the selling Holder or Holders selected by them not to exceed $15,000 shall be borne by the Company.

  
 (c) Registration on Form
S-3. All expenses, other than any underwriters’ discounts or commissions associated with Registrable Securities, incurred in connection with registrations requested pursuant to Section 1.4, including (without limitation) all
registration, filing, qualification, printers’ and accounting fees and the reasonable and documented fees and disbursements of one counsel for the selling Holder or Holders selected by them not to exceed $15,000 and counsel for the Company, and
shall be borne by the Company. 
  
 1.8 Underwriting
Requirements. In connection with any offering involving an underwriting of shares of the Company’s capital stock, the Company shall not be required under Section 1.3 to include any of the Holders’ securities in such
underwriting unless they accept the usual and customary terms of the underwriting as agreed upon between the Company and the underwriters selected by it (or by other persons entitled to select the underwriters), and then only in such quantity as the
underwriters determine in their sole discretion will not jeopardize the success of the offering by the Company. If the total amount of securities, including Registrable Securities, requested by shareholders to be included in such offering exceeds
the amount of securities to be sold, other than by the Company, that the underwriters determine in their sole discretion is compatible with the success of the offering, then the Company shall be required to include in the offering only that number
of such securities, including Registrable Securities, which the underwriters determine in their sole discretion will not jeopardize the success of the offering (the securities so included to be apportioned pro rata among the selling shareholders
according to the total amount of securities entitled to be included therein owned by each selling shareholder or in such other proportions as shall mutually be agreed to by such selling shareholders) but in no event shall (i) any shares being sold
by a shareholder exercising a 

  

 -8- 

 
demand registration right similar to that granted in Section 1.2 be excluded from such offering; (ii) or any securities held by an officer or director of the
Company (or an affiliate thereof, other than Microvision, Inc. or the University of Washington) be included if any securities held by any selling Holder are excluded; provided, however, that in a registration subsequent to the
Company’s initial public offering the number of UW Shares is not reduced below twenty percent (20%) of the number of securities to be registered in such registration. For purposes of the preceding parenthetical concerning apportionment, for any
selling shareholder which is a holder of Registrable Securities and which is a partnership or corporation, the partners, retired partners and shareholders of such holder, or the estates and family members of any such partners and retired partners
and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single “selling shareholder,” and any pro-rata reduction with respect to such “selling shareholder” shall be based upon the aggregate
amount of shares carrying registration rights owned by all entities and individuals included in such “selling shareholder,” as defined in this sentence. 
  
 1.9 Delay of Registration. No Holder shall have any right to obtain or seek an injunction restraining
or otherwise delaying any such registration as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 1. 
  
 1.10 Indemnification. In the event any Registrable Securities are included in a registration statement
under this Section 1: 
  
 (a) To the extent
permitted by law, the Company will indemnify and hold harmless each Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such Holder or underwriter within the meaning of the Securities Act
or the Securities Exchange Act of 1934, as amended (the “Exchange Act”), against any losses, claims, damages, or liabilities (joint or several) to which they may become subject under the Securities Act, the Exchange Act or other
federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations (each, a “Violation”): (i) any
untrue statement or alleged untrue statement of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or
alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act, any
state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law; and the Company will pay to each such Holder, underwriter or controlling person, as incurred, any legal or other
expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability, or action; provided, however, that the indemnity agreement contained in this subsection 1.10(a) shall not apply
to amounts paid in settlement of any such loss, claim, damage, liability, or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable to any Holder,
underwriter or controlling person for any such loss, claim, damage, liability, or action to the extent that it arises 

  

 -9- 

 
out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with
such registration by any such Holder, underwriter or controlling person. 
  
 (b) To the extent permitted by law, each selling Holder will indemnify and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who
controls the Company within the meaning of the Securities Act, any underwriter, any other Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any losses, claims,
damages, or liabilities (joint or several) to which any of the foregoing persons may become subject, under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in
respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in
connection with such registration; and each such Holder will pay, as incurred, any legal or other expenses reasonably incurred by any person indemnified pursuant to this subsection 1.10(b), in connection with investigating or defending any such
loss, claim, damage, liability, or action; provided, however, that the indemnity agreement contained in this subsection 1.10(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such
settlement is effected without the consent of the Holder, which consent shall not be unreasonably withheld; provided, that in no event shall any indemnity under this subsection 1.10(b) exceed the net proceeds from the offering received by such
Holder, except in the case of fraud by such Holder. 
  
 (c) Promptly after receipt by an indemnified party under this Section 1.10 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any
indemnifying party under this Section 1.10, deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires,
jointly with any other indemnifying party similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties
which may be represented without conflict by one counsel) shall have the right to retain one separate counsel, with the reasonable and documented fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by
the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such proceeding. The failure to deliver written
notice to the indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its ability to defend such action, shall relieve such indemnifying party of any liability to the indemnified party under this Section
1.10, but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Section 1.10. 
  

 -10- 

 (d) If the indemnification provided for in this Section 1.10 is held by a court of
competent jurisdiction to be unavailable to an indemnified party with respect to any loss, liability, claim, damage or expense referred to therein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall
contribute to the amount paid or payable by such indemnified party as a result of such loss, liability, claim, damage, or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the
indemnified party on the other in connection with the statements or omissions that resulted in such loss, liability, claim, damage or expense as well as any other relevant equitable considerations; provided, that in no event shall any
contribution by a Holder under this subsection 1.10(d) exceed the net proceeds from the offering received by such Holder, except in the case of fraud by such Holder. The relative fault of the indemnifying party and of the indemnified party shall be
determined by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party and the
parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission. 
  
 (e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 
  
 (f) The obligations of the Company and Holders under this Section 1.10 shall survive the completion of any
offering of Registrable Securities in a registration statement and the termination of this Agreement. 
  
 1.11 Reports Under Securities Exchange Act of 1034. With a view to making available to the Holders the benefits of Rule 144 promulgated
under the Securities Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to:

  
 (a) make and keep public information
available, as those terms are understood and defined in SEC Rule 144, at all times after ninety (90) days after the effective date of the first registration statement filed by the Company for the offering of its securities to the general public so
long as the Company remains subject to the periodic reporting requirements under Sections 13 or 15(d) of the Exchange Act; 
  
 (b) take such action, including the voluntary registration of its Common Stock under Section 12 of the Exchange Act, as is necessary to
enable the Holders to utilize Form S-3 for the sale of their Registrable Securities, such action to be taken as soon as practicable after the end of the fiscal year in which the first registration statement filed by the Company for the offering of
its securities to the general public is declared effective; 
  

 -11- 

 (c) file with the SEC in a timely manner all reports and other documents required of the
Company under the Securities Act and the Exchange Act; and 
  
 (d) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at
any time after ninety (90) days after the effective date of the first registration statement filed by the Company), the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements), or that it
qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company,
and (iii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC which permits the selling of any such securities without registration or pursuant to such form. 
  
 1.12 Assignment of Registration Rights. The rights to cause the
Company to register Registrable Securities pursuant to this Section 1 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee if (i) to parent corporation of or a subsidiary of such Holder or (ii) any
trust for the benefit of the Holder or a spouse or family member or (iii) to a transferee or assignee of at least 500,000 shares of such securities, provided the Company is, within a reasonable time after such transfer, furnished with written
notice of the name and address of such affiliate, transferee or assignee and the securities with respect to which such registration rights are being assigned, provided such transferee shall agree to be subject to all restrictions set forth in this
Agreement; and provided, further, that such assignment shall be effective only if immediately following such transfer the further disposition of such securities by the transferee or assignee is restricted under the Securities Act. For
the purposes of determining the number of shares of Registrable Securities held by a transferee or assignee, the holdings of transferees and assignees of a partnership who are partners or retired partners of such partnership (including spouses and
ancestors, lineal descendants and siblings of such partners or spouses who acquire Registrable Securities by sift, will or intestate succession) shall be aggregated together and with the partnership; provided that all assignees and transferees who
would not qualify individually for assignment of registration rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices or taking any action under Section 1. 
  
 1.13 Limitations on Subsequent Registration Rights. Except for
registration rights to be granted to Microvision, Inc. covering Class A Common Stock issuable upon conversion of shares of Series A Preferred Stock issuable upon exercise of warrants to be issued under the terms of the Company’s Convertible
Promissory Note dated February 28, 2001 payable to Microvision, Inc. (the “Convertible Note”), from and after the date of this Agreement, the Company shall not, without the prior written consent of the Holders of a majority of the
outstanding Registrable Securities, enter into any agreement with any holder or prospective holder of any securities of the Company which would allow such holder or prospective holder (a) to include such securities in any registration filed under
Section 1.2 hereof, unless under the terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent that the inclusion of his securities will not reduce the amount 

  

 -12- 

 
of the Registrable Securities of the Holders which is included, (b) to make a demand registration which could result in such registration statement being
declared effective prior to the earlier of either of the dates set forth in subsection 1.2(a) or within one hundred twenty (120) days of the effective date of any registration effected pursuant to Section 1.2. 
  
 1.14 “Market Stand-Off”
Agreement. Each Holder hereby agrees that, during the period of duration (up to, but not exceeding, one hundred eighty (180) days) specified by the Company and an underwriter of Common Stock or other securities of the Company,
following the effective date of a registration statement of the Company filed under the Securities Act, it shall not, to the extent requested by the Company and such underwriter, directly or indirectly sell, offer to sell, contract to sell
(including, without limitation, any short sale), grant any option to purchase or otherwise transfer or dispose of (other than to donees who agree to be similarly bound) any “securities of the Company held by it at any time during such period
except Common Stock included in such registration; provided, however, that: 
  
 (a) such agreement shall be applicable only to the first such registration statement of the Company which covers Common Stock (or other
securities) to be sold on its behalf to the public in an underwritten offering; and 
  
 (b) all officers and directors of the Company and all one-percent (1%) securityholders, and all other persons with registration rights
(whether or not pursuant to this Agreement) enter into similar agreements, except that the University of Washington shall only be required to do so to the extent required under the terms of the Restricted Stock Purchase Agreement between the Company
and the University of Washington dated October 20, 2000. 
  
 In
order to enforce the foregoing covenant, the Company may impose stop transfer instructions with respect to the Registrable Securities of each Holder (and the shares or securities of every other person subject to the foregoing restriction) until the
end of such period, and each Holder agrees that, if so requested, such Holder will execute an agreement in the form provided by the underwriter containing terms which are essentially consistent with the provisions of this Section 1.14. 

 
 Notwithstanding the foregoing, the obligations described in this Section
1.14 shall not apply to a registration relating solely to employee benefit plans on Form S-8 or similar forms which may be promulgated in the future, or a registration relating solely to an SEC Rule 145 transaction on Form S-4 or similar forms which
may be promulgated in the future. 
  
 1.15 Termination of
Registration Rights. No Holder shall be entitled to exercise any right provided for in this Section 1 after the earlier of (i) three (3) years following the consummation of a Qualified IPO, (ii) August     ,
2010, or (iii) such time as Rule 144 or another similar exemption under the Securities Act is available for the sale of all of such Holder’s shares during a ninety (90) day period without registration. 
  

 -13- 

 2. Covenants of the Company. 
  
 2.1 Delivery of Financial Statements. The Company shall deliver to each Holder of at least 500,000 shares of
Registrable Securities: 
  
 (a) as soon as
practicable, but in any event within ninety (90) days after the end of each fiscal year of the Company ending after the date hereof, an income statement for such fiscal year, a balance sheet of the Company and statement of shareholder’s equity
as of the end of such year, and a statement of cash flows for such year, such year-end financial reports to be in reasonable detail, prepared in accordance with generally accepted accounting principles (“GAAP”), and audited and
certified by an independent public accounting firm of nationally recognized standing selected by the Company; 
  
 (b) as soon as practicable, but in any event within forty-five (45) days after the end of each of the first three (3) quarters of each
fiscal year of the Company, an unaudited profit or loss statement, a statement of cash flows for such fiscal quarter, a summary of bookings and backlog and an unaudited balance sheet as of the end of such fiscal quarter; 
  
 (c) within thirty (30) days of the beginning of each fiscal
year, monthly financial projections for such fiscal year, operating budgets for such fiscal year and a fiscal business plan in reasonable detail; and 
  
 (d) with respect to the financial statements called for in subsections (b) of this Section 2.1, an instrument executed by the Chief
Financial Officer or President of the Company and certifying that such financials were prepared in accordance with GAAP consistently applied with prior practice for earlier periods (with the exception of footnotes that may be required by GAAP) and
fairly present the financial condition of the Company and its results of operation for the period specified, subject to normal and recurring year-end audit adjustment, provided that the foregoing shall not restrict the right of the Company to change
its accounting principles consistent with GAAP. 
  
 2.2
Inspection. The Company shall permit each Holder of at least 500,000 shares of Registrable Securities, at such Holder’s expense and at reasonable times and with advance notice, to visit and inspect the Company’s
properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its officers, all at such reasonable times as may be requested by the Investor; provided, however, that the Company shall
not be obligated pursuant to this Section 2.2 to provide access to any information which it reasonably considers to be a trade secret or similar confidential information. 
  
 2.3 Right of Participation. Subject to the terms and conditions specified in this paragraph 2.3, the Company
hereby grants to each Holder who holds at least 250,000 shares of Registrable Securities (a “Major Investor”) a right of participation with respect to future sales by the Company of its shares of, or securities convertible into or
exercisable for any shares of, any class of its capital stock (“Shares”). 
  

 -14- 

 Each time the Company proposes to issue and sell any Shares, the Company shall first make an offering of
such Shares to each Major Investor in accordance with the following provisions: 
  
 (a) The Company shall deliver a notice by certified mail (“Notice”) to the Major Investors stating (i) its bona fide
intention to offer such Shares and (ii) the number of such Shares. 
  
 (b) Within fifteen (15) calendar days after receiving the Notice, the Major Investor may elect to purchase or obtain, at the price and on the terms specified in the Notice, up to that portion of such Shares that
equals the proportion that the number of shares of common stock issued and held, or issuable upon conversion of the Registrable Securities then held, by such Major Investor bears to the total number of shares of common stock issued and held, or
issuable upon conversion of all convertible or exercisable securities then held, by all the Major Investors. 
  
 (c) If not all Shares that Investors are entitled to obtain pursuant to this Section 2.3(b) are elected to be obtained as provided in
Section 2.3(b), the Company may, during the sixty (60) day period following the expiration of the period provided in Section 2.3(b) hereof, offer the remaining unsubscribed portion of such Shares to any person or persons at a price not less than,
and upon terms no more favorable to the offeree than, those specified in the Notice. If the Company does not sell such Shares or enter into an agreement for the sale of the Shares within such period, or if such agreement is not consummated within
sixty (60) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such Shares shall not be offered unless first reoffered to the Major Investors in accordance herewith. 
  
 (d) The right of participation set forth in this Section 2.3
shall not apply to Shares issued or issuable: (i) upon conversion of shares of Series A Preferred Stock or Series B Preferred Stock; (ii) upon conversion of Class B Common Stock into Class A Common Stock; (iii) to officers, directors or employees
of, or consultants to, the Company pursuant to stock option or stock purchase plans or agreements on terms approved by the Board of Directors; (iv) in connection with equipment financings or similar transactions, or in connection with strategic
investments or corporate partnering transactions, the terms of which are approved by the Board of Directors of the Corporation; (v) as a dividend or distribution on Series A Preferred Stock; (vi) under the terms of the Convertible Note; (vii) for
which adjustment of the Conversion Price of the Series A Preferred Stock or Series B Preferred Stock (as defined in the Company’s Amended and Restated Articles of Incorporation (the “Articles of Incorporation”)) is made
pursuant to the Articles of Incorporation; (viii) in connection with a Qualified IPO; (ix) pursuant to the acquisition of another business entity or business segment of any such entity by the Company by merger, purchase of substantially all the
assets or other reorganization whereby the Company will own more than fifty percent (50%) of the voting power of such business entity or business segment of any such entity; (x) upon the exercise, conversion or exchange of any security outstanding
as of the date hereof or securities issued or issuable pursuant to subsections 

  

 -15- 

 
(i) through (ix) above; or (xi) any right, option or warrant to acquire any security convertible into the securities issued or issuable pursuant to
subsections (i) through (x) above. 
  
 The right of first offer
set forth in this Section 2.3 may not be assigned or transferred, except that (a) such right is assignable by each Holder to any wholly owned subsidiary or parent of, or to any corporation or entity that is, within the meaning of the Act,
controlling, controlled by or under common control with, any such Holder, and (b) such right is assignable between and among any of the Holders. 
  
 2.4 Stock Vesting. All stock options and other stock equivalents issued after the date of this Agreement to employees, directors,
consultants and other service providers shall be subject to vesting as determined by the Board of Directors or a committee thereof composed of non-employee directors. 
  
 2.5 Employee Non-Disclosure and Assignment of Inventions Agreement. Except as provided in the Purchase
Agreement, the Company and each of its employees shall have entered into the Company’s standard form Employee Agreement, in substantially the form provided to the Investors. 
  
 2.6 [Reserved] 
  
 2.7 Termination of Covenants. 
  
 (a) The covenant set forth in Section 2.1, Section 2.2, Section 2.3 and Section 2.5 shall terminate as to each. Holder and be of no
further force or effect (i) immediately prior to the consummation of a Qualified IPO, or (ii) when the Company shall sell, convey, or otherwise dispose of or encumber all or substantially all of its property or business or merge into or consolidate
with any other corporation (other than a wholly-owned subsidiary corporation) or effect any other transaction or series of related transactions in which the holders of the Company’s outstanding voting stock immediately prior to such transaction
own, immediately after such transaction, securities representing less than fifty percent (50%) of the voting power of the corporation of the acquiring, surviving or continuing corporation or corporations, as applicable, provided that this
subsection (ii) shall not apply to a merger effected exclusively for the purpose of changing the domicile of the Company. 
  
 (b) The covenants set forth in Sections 2.1 and 2.2 shall terminate as to each Holder and be of no further force or effect when the
Company first becomes subject to the periodic reporting requirements of Sections 13 or 15(d) of the Exchange Act, if this occurs earlier than the events described in Section 2.7(a) above. 
  
 3. Miscellaneous. 
  
 3.1 Successors and Assigns. Except as otherwise provided in this Agreement, the terms and conditions of this Agreement shall inure to the
benefit of and be binding upon the respective permitted successors and assigns of the parties (including transferees of any of the 

  

 -16- 

 
Series A Preferred Stock, Series B Preferred Stock or any Class A Common Stock issued upon conversion thereof). Nothing in this Agreement, express or
implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this
Agreement. 
  
 3.2 Amendments and Waivers. Any term
of this Agreement may be amended or waived only with the written consent of the Company and the holders of a majority of the Registrable Securities then outstanding. Any amendment or waiver effected in accordance with this paragraph shall be binding
upon each holder or Holder of any Registrable Securities then outstanding, each future holder or Holder of all such Registrable Securities, and the Company. Notwithstanding the foregoing, this Agreement may be amended with only the written consent
of the Company for the sole purpose of including additional purchasers of Series B Preferred Stock as “Investors” and “Holders” as contemplated by the Purchase Agreement. The Company shall provide a copy of any amendment to this
Agreement pursuant to this Section 3.2 to all other parties hereto. 
  
 3.3 Notices. Unless otherwise provided, any notice required or permitted by this Agreement shall be in writing and shall be deemed sufficient upon delivery, when delivered personally or by overnight courier or sent by telegram or fax, or forty-eight (48) hours after being deposited in the U.S. mail, as certified or
registered mail, with postage prepaid, and addressed to the party to be notified at such party’s address or fax number as set forth below or on Exhibit A hereto or as subsequently modified by written notice. 
  
 3.4 Severability. If one or more provisions of this Agreement
are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (a) such provision
shall be excluded from this Agreement, (b) the balance of the Agreement shall be interpreted as if such provision were so excluded and (c) the balance of the Agreement shall be enforceable in accordance with its terms. 
  
 3.5 Governing Law. This Agreement and all acts and transactions
pursuant hereto shall be governed, construed and interpreted in accordance with the laws of the State of Washington, without giving effect to principles or conflicts of laws. 
  
  
 3.6 Counterparts. This Agreement
may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
  

3.7 Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and not to be considered in
construing or interpreting this Agreement. 
  
 3.8
Aggregation of Stock. All shares of the Preferred Stock held or acquired by (i) affiliated entities or persons or (ii) persons or entities under common investment management, 

  

 -17- 

 
shall be aggregated together for the purpose of determining the availability of any rights as a Holder under this Agreement. 
  
 3.9 Specific Enforcement. It is agreed and understood
that monetary damages would not adequately compensate an injured party for the breach of this Agreement by any party, that this Agreement shall be specifically enforceable, and that any breach or threatened breach of this Agreement shall be the
proper subject of a temporary or permanent injunction or restraining order. Further, each party hereto waives any claim or defense that there is an adequate remedy at law for such breach or threatened breach. 
  
 (signature page follows) 
  

 -18- 

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	 By:
	 	 /s/ Thomas D. Mino
	 	 	 	 By:
	 	 
	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 
	 	 	 	 	 	 	 	 	

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 MICROVISION

					
	 By:
	 	 	 	 	 	 By:
	 	 /s/ Richard F. Rutkowski

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 Richard F. Rutkowski

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 CEO

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 Acorn Ventures, Inc.

					
	 By:
	 	 	 	 	 	 By:
	 	 /s/ Gregory W. Forge

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 Gregory W. Forge

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 General Counsel

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	8/18/03
					
	 By:
	 	 	 	 	 	 By:
	 	 /s/ Jacqueline Brandwynne

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 Jacqueline Brandwynne

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 Investor

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
	 	 	 	 	 
	LUMERA CORPORATION	 	 	 	 
					
	By:	 	 	 	 	 	 By:
	 	 /s/ Gary D. Glouner, Jr.

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 Gary D. Glouner, Jr.

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 Trustee

	 	 	 	 	 	 	 	 	 D.C. Glouner Trust

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
	 	 	 	 	 
	LUMERA CORPORATION	 	 	 	 
					
	By:	 	 	 	 	 	 By:
	 	 /s/ James A. Nordstrom

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 James A. Nordstrom

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

	 	 	 	 	 	 	 	 	 

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
	 	 	 	 	 
	LUMERA CORPORATION	 	 	 	 
					
	By:	 	 	 	 	 	 By:
	 	 /s/ James A. Nordstrom

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 James A. Nordstrom

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 Manager

	 	 	 	 	 	 	 	 	 

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
	 	 	 	 	 
	LUMERA CORPORATION	 	 	 	 
					
	By:	 	 	 	 	 	 By:
	 	 /s/ Michael Norinsberg

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 Michael Norinsberg

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

	 	 	 	 	 	 	 	 	 

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
	 	 	 	 	 
	LUMERA CORPORATION	 	 	 	 
					
	By:	 	 	 	 	 	 By:
	 	 /s/ Wayne M. Perry

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 Wayne M. Perry

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

	 	 	 	 	 	 	 	 	 

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
	 	 	 	 	 
	LUMERA CORPORATION	 	 	 	 Spanish Caravan Investments, LLC

					
	By:	 	 	 	 	 	 By:
	 	 /s/ C. James Judson

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 C. James Judson

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 Member/Manager

	 	 	 	 	 	 	 	 	 

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 	 	 	 	 VITERBI GROUP, LLC

	 LUMERA CORPORATION
	 	 	 	 
					
	By:	 	 	 	 	 	By:	 	/s/ Andrew J. Viterbi
	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	Name:	 	Andrew J. Viterbi
	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	President

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	By:	 	 	 	 	 	By:	 	/s/ Walter J. Lack
	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	Name:	 	Walter J. Lack
	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	By:	 	 	 	 	 	By:	 	/s/ Brien Stafford
	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	Name:	 	Brien Stafford
	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	By:	 	 	 	 	 	By:	 	/s/ Kenneth S. Elie
	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	Name:	 	Kenneth S. Elie
	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	By:	 	 	 	 	 	By:	 	/s/ Thomas M. Walker
	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	Name:	 	Thomas M. Walker
	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	By:	 	 	 	 	 	By:	 	/s/ Ronald D. Baunsgard
	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	Name:	 	Ronald D. Baunsgard
	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	Individual

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	By:	 	 	 	 	 	By:	 	/s/ David J. Martinson
	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	Name:	 	David J. Martinson
	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	Investor

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	 By:
	 	 	 	 	 	 By:
	 	 /s/ Charles H. Putney

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 Charles H. Putney

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	 By:
	 	 	 	 	 	 By:
	 	 /s/ Robert Faust

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 Robert & Judith Faust Trust

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 Trustees

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	By:	 	 	 	 	 	By:	 	 /s/ Peter R. Marsh

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	Name:	 	Peter R. Marsh
	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	By:	 	 	 	 	 	 By:
	 	 /s/ George M. Galpin

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 George M. Galpin

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	By:	 	 	 	 	 	 By:
	 	 /s/ James W. Foster

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 James W. Foster

					
	 	 	 	 	 	 	 By:
	 	 /s/ Margaret A. Foster

	 	 	 	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 Margaret A. Foster

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
			
	 LUMERA CORPORATION
	 	 	 	 
					
	By:	 	 	 	 	 	 By:
	 	 /s/ Suzanne McAnena

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 Suzanne McAnena

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 Investor

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
	 	 	 	 	 
	LUMERA CORPORATION	 	 	 	 
					
	By:	 	 	 	 	 	 By:
	 	 /s/ Stephan Chase

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 Stephan Chase

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 The parties have executed this Investors’ Rights Agreement as of the date first above written.

  

									
	COMPANY:	 	 	 	INVESTORS:
	 	 	 	 	 
	LUMERA CORPORATION	 	 	 	 
					
	By:	 	 	 	 	 	 By:
	 	 /s/ R. A. Clyborne

	 	 	
	 	 	 	 	 	

	 	 	 	 	 	 	 Name:
	 	 R. A. Clyborne

	 	 	 	 	 	 	 	 	(print)
	 	 	 	 	 	 	 Title:
	 	 
	 	 	 	 	 	 	 	 	

  
 [SIGNATURE PAGE TO
LUMERA CORPORATION 
 AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 
  

 EXHIBIT A  
  

INVESTORS 
  
 Investor Name and Address 
  
 Cisco Systems, Inc. 
 170 W. Tasman Dr. 
 San Jose, CA 95134 
  
 Microvision, Inc. 
 Richard F. Rutkowski, President 
 19910 North Creek Parkway 
 Bothell, WA 98011 
  
 AAQ Investments, LLC 
 Andrew Quartner, Managing
Member 
 6921 Mountain Gate Dr. 
 Bethesda, MD 20817 

 
 Acorn Ventures, Inc. 
 Rufus W. Lumry, President 
 1309 114th Avenue SE, Suite 200 
 Bellevue, WA 98004 
  
 Acorn Ventures IS, LLC 
 Rufus M. Lumry,
Managing Member 
 1309 114th Avenue SE, Suite 200 
 Bellevue, WA 98004 
  
 ADS 1212 Trust 
 1301 5th Ave., Suite 300 
 Seattle, WA 98101 
  
 The Barksdale Group, LLC 
 c/o Peter L.S. Currie, Managing Member 
 2730 Sand Hill Rd., Suite 100 
 Menlo Park, CA 94025 
  
 Barksdale Group Ventures I, LP 
 c/o Peter L.S. Currie, General Partner 
 2730 Sand Hill Rd., Suite 100 
 Menlo Park, CA 94025 
  

 Investor Name and Address 
  
 Barksdale Investments, LLC 
 c/o James L.
Barksdale, Managing Member 
 2730 Sand Hill Rd., Suite 100 
 Menlo Park, CA 94025 
  
 Barksdale Ventures, LLC 
 c/o James L. Barksdale, Managing Member 
 2730 Sand Hill Rd., Suite 100

 Menlo Park, CA 94025 
  
 Kenneth Steven Blakeslee 
 Regatta View 
 River Road 
 Taplow, Berkshire SL6 0BG 
 U.K. 
  
 Jacqueline Brandwynne 
 649 Stone Canyon Rd. 
 Los
Angeles, CA 90077 
  
 Chais Investments, Ltd. 
 Stanley Chais, President 
 611 N. Oakhurst Dr. 
 Beverly Hills, CA 90210 
  
 Peter L.S. Currie 
 2730 Sand Hill Rd., Suite 100 
 Menlo Park, CA 94025 
  
 Gian F. DeCaro

 1637 Broadmoor Dr. E 
 Seattle, WA 98112 
  
 Margaret Elardi Revocable Living Trust 
 c/o Margaret Elardi, Trustee 
 3411 Las Vegas Blvd. S 
 Las Vegas, NV 89109 
  
 David Elliman 
 923 Fifth Ave. 
 New York, NY 10021-2649 
  

 -2- 

 Investor Name and Address 
  
 Robert D. Ferry 
 1221 S. Congress Ave. #524

 Austin, TX 78704 
  
 Gregory W. Forge 
 c/o Acorn Ventures, Inc. 
 1309 114th Avenue SE, Suite 200 
 Bellevue, WA 98004 
  
 D.C. Glouner Trust 
 c/o Gary D. Glouner, Jr., Trustee 
 14491 NE 57th St. 
 Bellevue, WA 98007 
  
 Judy Grossman 

277 N. Ave 
 Westport, CT 06880 
  
 Arthur W. Harrigan, Jr. 
 999 3rd Ave., Suite 4400 
 Seattle, WA 98104 
  
 Steven W. Hooper 
 11400 SE 6th St., Suite 100 
 Bellevue, WA 98004 
  
 Nicolas Kauser 
 2825 96th Ave. NE 
 Bellevue, WA 98004 
  
 Koala Venture Partners I, LLC 
 Rene Matthews,
Managing Member 
 700 East Blvd., Suite One 
 Charlotte, NC 28203

  
 LCM Partners, LLC 
 Jeff E. Flohr, Managing Member

 4314 E. Madison 
 Seattle, WA 98112 
  
  

 46 

 Investor Name and Address 
  
 James A. Nordstrom 
 P.O. Box 676 
 Medina, WA 98039 
  
 Northern Stream Capital 
 P.O. Box 676 
 Medina, WA 98039 
  
 Michael Norinsberg 
 Suite 145A NYC Terminal Market 
 Bronx, NY 10474 
  
 Christopher O’Donnell 
 3 Pine Lane 
 Rye, NY 10580 
  
 Wayne M. Perry 
 11400 SE 6th Street, Suite 100 
 Bellevue, WA 98009 
  
 Pickwick Group, LP 
 c/o James L. Barksdale, General Partner 
 2730 Sand Hill Road., Suite 100 
 Menlo Park, CA 94025 
  
 Pomeroy Investments, L.L.C. 
 Darla Pomeroy, Manager 
 1519 Barley Mill Rd. 
 Wilmington, DE 19807 
  
 David M. Ransom 
 2269 Cathedral Ave. NW

 Washington, DC 20008 
  
 John C. Rosling 
 4214 53rd Ave. NE 
 Seattle, WA 98105 
  
 SMS Trust 
 1301 5th Ave., Suite 3000 
 Seattle, WA 98101 
  

 -4- 

 Investor Name and Address 
  
 Stephen Scherba, Jr. and Elain P. Scherba, 
     as Tenants in Common 
 509 Crockett St. 
 Seattle, WA 98109-2136 
  
 Spanish Caravan Investments, L.L.C.

 c/o C. James Judson, Managing Member 
 2300 Carillon Point

 Kirkland, WA 98033-7353 
  
 Andrew Viterbi and Erna Viterbi 
 Viterbi Family Venture Capital 

4370 La Jolla Village Dr., #675 
 San Diego, CA 92122 
  
 Washington Research Foundation 
 Ronald S. Howell, President 
 2815 Eastlake Ave. E, Suite 300 
 Seattle, WA 98102 
  
 Weibling Family Trust U/A
dtd 7/24/00 
 c/o Dennis M. Weibling, Trustee 
 P.O. Box 2789

 Kirkland, WA 98083-2789 
  
 You Lucky Dog Trust 
 1301 5th Ave., Suite 3000 
 Seattle, WA 98101 
  
 Larry Zalk 
 51 Falmouth St. 
 Short Hills, NJ 07078 
  
 Walter Lack 
 10100 Santa Monica Boulevard

 16th Floor 

Los Angeles, CA 90067 
  

 -5- 

 Investor Name and Address 
  
 Brien Stafford 
 10407 SE 30th Street 
 Bellevue, WA 98004

  
 K.S. and Deborah Elie 
 7 Forest Trail 
 Petaluma, CA 94952 
  
 Tom Walker 
 19910 North Creek Parkway 
 Bothell, WA 98011 
  
 Ronald D. Baunsgard 
 941 Utsalady Road

 Camano Island, WA 98282 
  
 David J. Martinson 
 1900 W. Nickerson St. 
 #116-11 
 Seattle, WA 98119 
  
 Charles H. Putney and Marla J. Putney, 
 TTEES, u/a 1/4/96 The Charles H. Putney 
 Trust 
 c/o UBS Financial Services Inc. 
 805 SW Broadway 
 Suite 26000 
 Portland, OR 97205 
  
 Robert & Judith Faust Trust 
 4321 Lemp Avenue 
 Studio City, CA 91604-2814 
  
 Peter Marsh and Barbara Jo Marsh, 
 Joint
Tenants in Common 
 c/o Adair Homes, Inc. 
 1111 SW 170 St.

 Beaverton, OR 97006 
  
 George M. Galpin 
 23426 Woodway Park Rd. 
 Woodway, WA 98020 
  

 -6- 

 Investor Name and Address 
  
 James W. Foster, Jr. and Margaret A. Foster 
 5236 South Parview Drive 
 Charlotte, NC 28226 
  
 Suzanne B. McAnena 
 4132 Maloney Road 
 Knoxville, TN 37920 
  
 Stephan Chase 
 4 Savannah Court 
 Bethesda, MD 20817 
  
 R.A. Clyborne 
 9325 Olympic Drive 
 Edmonds, WA 98020 
  

 -7-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00066-of-00352.parquet"}]]